האיגוד הישראלי לרפואת משפחה
כעת 6832 ערכים
רופאים, הרשמו עכשיו למועדון העורכים כניסה עקבו אחרינו בפייסבוק
האיגוד הישראלי לרפואת משפחה
רופאים, הרשמו עכשיו למועדון העורכים כניסה עקבו אחרינו בפייסבוק
כעת 6832 ערכים
האיגוד הישראלי לרפואת משפחה

המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת/ביבליוגרפיה למהדורת 2022

מתוך ויקירפואה

Preventative (1).png

המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת
מאת איגוד רופאי המשפחה בישראל, האגף למדיניות רפואית, ההסתדרות הרפואית בישראל

הפרק הקודם

תוכן עניינים > פרק #27: המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת/ביבליוגרפיה למהדורת 2022

המלצות כוח המשימה הישראלי בנושא
קידום בריאות ורפואה מונעת
Ambox warning blue.png
ערך זה הוא הנחיה קלינית סגורה לעריכה
המלצות כוח המשימה.png
שם הפרק ביבליוגרפיה למהדורת 2022
עורך מדעי פרופסור אמנון להד, פרופ' חוה טבנקין, ד"ר תם אקסלרוד
מוציא לאור ההסתדרות הרפואית בישראל, האגף למדיניות רפואית, איגוד רופאי המשפחה בישראל
מועד הוצאה אוקטובר 2022
מספר עמודים 284
קישור באתר ההסתדרות הרפואית
Logo small.gif
  1. Wilson J, Junger G. The principles and practice of screening for disease. 1968.
  2. US Preventive Services Task Force. Grade Definitions After July 2012.
  3. Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, et al. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System. Circulation. 2016;133(14).
  4. משרד הבריאות. תדריך לביצוע הערכות התפתחות לתינוקות ולפעוטות עד גיל 6 שנים. 12/2016
  5. United States Preventive Services Task Force. Guide to clinical Preventive Service. 2nd ed. Baltimore, MD: Williams & Wilkins ; 1996.
  6. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health care. Canada Communication group publishing ; 1998.
  7. Braveman P, Tarimo E. Screening in Primary Health Care:Setting Priorities With Limited Resources. WHO Publication ; 1994.
  8. משרד הבריאות. שינויים בשגרת החיסונים, 2003
  9. משרד הבריאות. הנחיות משרד הבריאות בנושא מעקב גדילה והתפתחות ילדים עד גיל 5 +עדכונים,
  10. ארגון רופאי הילדים. המלצות הוועדה המייעצת לארגון רופאי הילדים, 1992
  11. Valman HB. ABC of one to seven. Febrile convulsions. BMJ. 1993;306)6894).
  12. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Medical Journal of Australia. 1989;150(11).
  13. Temte JL. 2007 Childhood and adolescent immunization schedules: Evolution or intelligent design? Vol. 75, American Family Physician. 2007.
  14. משרד הבריאות. מתן חיסון פעיל נגד אבעבועות רוח. 11/2007
  15. משרד הבריאות. עדכון תדריך החיסונים של המחלקה לאפידמיולוגיה, 2007
  16. CDC. CDC Health Information for International Travel. 2008.
  17. Gahlinger PM. Motion sickness: How to help your patients avoid travel travail. Postgraduate Medicine. 1999;106(4).
  18. אורקין י, אמיתי י, חונוביץ מ. בריאות התינוק והפעוט מידע שימושי לצוות טיפת חלב. דיונון, 2011
  19. משרד הבריאות. בדיקות סקר ביילודים לזיהוי מוקדם של מחלת תת-תריסיות, מחלת פנילקטונוריה ומחלות אחרות. 17/2009
  20. משרד הבריאות. ביצוע בדיקות דימות החושפות ילדים וילודים לקרינה מייננת. 18/2009
  21. משרד הבריאות. תדריך למניעת אנמיה וחוסר ברזל בתינוקות ובפעוטות. 17/2012
  22. ראש שירותי בריאות הציבור. שירות בריאות לתלמיד. 16/2012
  23. Beltran-Aguilar ED, Barker LK, Canto MT, Dye BA, Gooch BF, Griffin SO, et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveillance summaries : Morbidity and mortality weekly report Surveillance summaries / CDC. 2005;54(3).
  24. Petersen PE. Global policy for improvement of oral health in the 21st century - Implications to oral health research of World Health Assembly 2007, World Health Organization. Vol. 37, Community Dentistry and Oral Epidemiology. 2009.
  25. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 01/2020
  26. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 16/2014
  27. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 08/2019
  28. קידום, הגנה ותמיכה בהנקה בטיפות חלב - חוזר משרד הבריאות - Promoting breastfeeding in family health centers
  29. Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. New England Journal of Medicine. 2016 May 5;374(18).
  30. Meek JY, Noble L. Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics. 2022 Jul 1;150(1).
  31. ההמלצות התזונתיות החדשות - משרד הבריאות
  32. מדריך לאנשי מקצוע להזנת התינוק והפעוט - חוזר משרד הבריאות - Infant and toddler feeding guide for healthcare professionals
  33. שינה בטוחה לתינוקות
  34. משרד הבריאות. הנחיות לשימוש בתכשירי פלואוריד. הנחיות בריאות השן מס' 3.2, 2021
  35. המחלות הנבדקות בבדיקות סקר ביילודים
  36. איתור אי יציבות מפרק הירך ביילודים ובתינוקות - חוזר משרד הבריאות - Screening for hip instability in neonates and infants
  37. עמותת גושן. פורטל בריאות ורווחת הילד בקהילה
  38. נוהל לאיתור נשים בסיכון לדיכאון בהיריון ולאחר לידה - חוזר משרד הבריאות
  39. Fixler DE, Laird WP. Validity of mass blood pressure screening in children. Pediatrics. 1983;72(4).
  40. Zadik Z, Sthoeger D, Blachar Y. Blood pressure determinations in Israeli schoolchildren aged 5 to 14 years. Israel Journal of Medical Sciences. 1987;23(7).
  41. Morais T, Bernier M, Turcotte F. Age- and sex-specific prevalence of scoliosis and the value of school screening programs. American Journal of Public Health. 1985;75(12).
  42. US Preventive Services Task Force. Screening for Adolescent Idiopathic Scoliosis. JAMA. 1993;319)2(:165-72.
  43. Willers U, Svensson O, Hedlund R, Normelli H, Aaro S. Long-term results of boston brace treatment on vertebral rotation in idiopathic scoliosis. Spine )Phila Pa 1976). 1993;18(4).
  44. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. Journal of Urology. 1994;151(5).
  45. מניעה וטיפול בהשמנה משרד הבריאות
  46. עידוד פעילות גופנית משרד הבריאות
  47. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית 01/2020
  48. Palti H. Blood pressure assessment in children. Isr J Med Sci. 1987;23(7).
  49. Horan MJ, Falkner B, Kimm SYS. Report of the second task force on blood pressure control in children - 1987 - Task Force on Blood Pressure Control in Children. Pediatrics. 1987;79(1).
  50. Baron AE, Freyer B, Fixler DE. Longitudinal blood pressures in blacks, whites, and mexican Americans during adolescence and early adulthood. American Journal of Epidemiology. 1986;123(5).
  51. Weinstein SL, Dolan LA, Spratt KF, Peterson KK, Spoonamore MJ, Ponseti I v. Health and Function of Patients with Untreated Idiopathic Scoliosis: A 50-Year Natural History Study. J Am Med Assoc. 2003;289(5).
  52. Berg AO. Screening for depression: Recommendations and rationale. Vol. 66, American Family Physician. 2002.
  53. Froom J, Schlager DS, Steneker S, Jaffe A. Detection of major depressive disorder in primary care patients. The Journal of the American Board of Family Practice / American Board of Family Practice. 1993;6(1).
  54. פעילות גופנית וספורט בילדים ובבני נוער - נייר עמדה 2019
  55. US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Vol. 1. Rockville, MD: Agency for Healthcare Research and Quality (US); 2002.
  56. קנישקווי ב, אמיתי י, חונוביץ מ. בריאות התלמיד: מידע שימושי. ירושלים: משרד הבריאות 2003
  57. Berg AO. Screening for skin cancer: Recommendations and rationale. Vol. 65, American Family Physician. 2002.
  58. Lamberg L. "Epidemic" of malignant melanoma: True increase or better detection? Vol. 287, Journal of the American Medical Association. 2002.
  59. Soldatos CR, Allaert FA, Ohta T, Dikeos DG. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Medicine. 2005;6(1).
  60. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Archives of Internal Medicine. 2006;166(16).
  61. Kahn-Greene ET, Killgore DB, Kamimori GH, Balkin TJ, Killgore WDS. The effects of sleep deprivation on symptoms of psychopathology in healthy adults. Sleep Medicine. 2007;8(3).
  62. Alvarez GG, Ayas NT. The impact of daily sleep duration on health: a review of the literature. Vol. 19, Progress in cardiovascular nursing. 2004.
  63. Rains JC, Poceta JS. Headache and sleep disorders: Review and clinical implications for headache management. Vol. 46, Headache. 2006.
  64. Wolkove N, Elkholy O, Baltzan M, Palayew M. Sleep and aging: 1. Sleep disorders commonly found in older people. Vol. 176, CMAJ. 2007.
  65. Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Vol. 27, Pharmacotherapy. 2007.
  66. McGuire S. Institute of medicine. 2010. Strategies to reduce sodium intake in the united states. Washington, dc: The national academies press. Vol. 1, Advances in Nutrition. 2010.
  67. Sacks FM, Campos H. Dietary Therapy in Hypertension. New England Journal of Medicine. 2010;362(22).
  68. Gidding SS, Lichtenstein AH, Faith MS, Karpyn A, Mennella JA, Popkin B, et al. Implementing american heart association pediatric and adult nutrition guidelines. Vol. 119, Circulation. 2009.
  69. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368)9548).
  70. WCRF. Food, nutrition, physical activity and the prevention of cancer. The American Institute for Cancer Research )AICR(; World Cancer Research Fund )WCRF UK( World Cancer Research Fund International. 2007.
  71. Morrow JW, Keels MA, Hale KJ, Thomas HF, Davis MJ, Czerepak CS, et al. Preventive oral health intervention for pediatricians. Vol. 122, Pediatrics. 2008.
  72. Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutrition. 2004;7)1a).
  73. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet. New England Journal of Medicine. 2008;359(3).
  74. Widenhorn-Muller K, Hille K, Klenk J, Weiland U. Influence of having breakfast on cognitive performance and mood in 13-to 20-year-old high school students: Results of a crossover trial. Pediatrics. 2008;122(2).
  75. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Washington DC; 2008.
  76. Meriwether RA, Lee JA, Lafleur AS, Wiseman P. Physical activity counseling. Vol. 77, American Family Physician. 2008.
  77. Marcus. Erratum: Physical activity intervention studies: What we know and what we need to know: A scientific statement from the American Heart Association Council on nutrition, physical activity, and metabolism )subcommittee on physical activity(; Council on cardiovascular disease in the young. Vol. 122, Circulation. 2010.
  78. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. Exercise training for type 2 diabetes mellitus: Impact on cardiovascular risk: A scientific statement from the american heart association. Circulation. 2009;119(25).
  79. Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MSV. Physical activity and risk of ischemic stroke in the Northern Manhattan study. Neurology. 2009;73)21).
  80. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet. 2009;374)9702).
  81. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Vol. 41, Medicine and Science in Sports and Exercise. 2009.
  82. זלר ל, סוקניק ש. הקשר שבין עיסוק בספורט לבין התפתחות אוסטאוארתריטיס של הברכיים. הרפואה
  83. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA - Journal of the American Medical Association. 2008;300(9).
  84. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010 Dec 1;33(12).
  85. Hornsby W, Albright A. Diabetes. In: Durstine J, Moore G, editors. ACSM's Exercise Management for Persons with Chronic Diseases and Disabilities. 3rd ed. Williams & Wilkins; 2009. p. 182-91.
  86. Elsawy B, Higgins KE. Physical activity guidelines for older adults. American Family Physician. 2010;81(1).
  87. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Medicine and Science in Sports and Exercise. 2011;43(7).
  88. Lee DC, Sui X, Artero EG, Lee IM, Church TS, McAuley PA, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men the Aerobics Center Longitudinal Study. Circulation. 2011;124(23).
  89. Haug C. The risks and benefits of HPV vaccination. Vol. 302, JAMA - Journal of the American Medical Association. 2009.
  90. Rothman SM, Rothman DJ. Marketing HPV vaccine: Implications for adolescent health and medical professionalism. Vol. 302, JAMA - Journal of the American Medical Association. 2009.
  91. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA - Journal of the American Medical Association. 2009;302(7).
  92. Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology. 2012;13(1).
  93. Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology. 2012;13(1).
  94. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia. New England Journal of Medicine. 2011;365(17).
  95. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, et al. Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males. New England Journal of Medicine. 2011;364(5).
  96. Read TRH, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus )HPV( vaccination programme. Sexually Transmitted Infections. 2011;87(7).
  97. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet. 2011;377)9783).
  98. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. New England Journal of Medicine. 2005 Jun 2;352(22).
  99. Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews. 2011;
  100. USPSTF A-Z Topic Guide.
  101. Israel Center for Disease Control and MOH Department of Health Promotion and Education. INHIS and KAP surveys. 2003.
  102. איגוד רופאי הילדים. הנחיות והמלצות בנושא: רפואת מתבגרים. המפגש הרפואי עם בני נוער. ההסתדרות הרפואית בישראל, 2000
  103. טיפול בחומצה פולית למניעת מומים מולדים בתעלה העצבית - NTDs - neural tube defects - חוזר משרד הבריאות
  104. Sox HJ. Preventive Health Services in Adults. New England Journal of Medicine. 1994;330(22).
  105. Implementing preventive services. Based on papers prepared for the International Symposium on Preventive Services in Primary Care: Issues and Strategies. L'Esterel, Quebec, Canada, October 4-7, 1987. Am J Prev Med. 1988;4)4 Suppl).
  106. Braveman P, Tarimo E. Screening in primary health care: setting priorities with limited resources. 1994.
  107. Dobrossy L. Prevention in primary care: recommendations for promoting good practice. 1994.
  108. Patterson C, Chambers LW. Preventive health care. The Lancet. 1995 Jun;345)8965).
  109. משרד הבריאות. הנחיות משרד הבריאות בנושא מעקב נשים בהיריון+עדכונים, 1995
  110. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of Prenatal Ultrasound Screening on Perinatal Outcome. New England Journal of Medicine. 1993;329(12).
  111. Berkowitz RL. Should Every Pregnant Woman Undergo Ultrasonography? New England Journal of Medicine. 1993;329(12).
  112. Bernaschek G, Stuempflen I, Deutinger J. The value of sonographic diagnosis of fetal malformations: Different results between indication-based and screening-based investigations. Prenatal Diagnosis. 1994;14(9).
  113. Bragonier JR, Bemis-Heys RL. Cost-effectiveness in the provision of primary health care services for women. Primary Care Update for Ob/Gyns. 1994;1(6).
  114. Roccella EJ. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure )JNC V). Archives of Internal Medicine. 1993;153(2).
  115. Pyorala K, Backer G de, Graham I, Poole-wilson P, Wood D. Prevention of coronary heart disease in clinical practice: Recommendations of the task force of the european society of cardiology, european atherosclerosis society and european society of hypertension. European Heart Journal. 1994;15(10).
  116. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society consensus conference: 1. Introduction. Vol. 149, CMAJ. 1993.
  117. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. New England Journal of Medicine. 1995;333)20).
  118. Summary of the Second Report of the National Cholesterol Education Program )NCEP( Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults )Adult Treatment Panel II). JAMA: The Journal of the American Medical Association. 1993;269(23).
  119. Willett WC. Diet and health: What should we eat? Science )1979). 1994;264)5158).
  120. Heaney RP. Optimal Calcium Intake. Vol. 274, JAMA: The Journal of the American Medical Association. 1995.
  121. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The Primary Prevention of Coronary Heart Disease in Women. New England Journal of Medicine. 1995 Jun 29;332(26).
  122. Austoker J, Sanders D, Fowler G. Cancer Prevention in Primary Care: Smoking and cancer: Smoking cessation. BMJ. 1994;308)6942).
  123. Austoker J. Melanoma: Prevention and early diagnosis. Vol. 308, British Medical Journal. 1994.
  124. Menczer J. The case against cytological mass screening for cervical cancer in Israel. Vol. 122, Harefuah. 1992.
  125. Blum A, Solberg E. The role of the family physician in ending the tobacco pandemic. Vol. 34, Journal of Family Practice. 1992.
  126. Kottke TE, Solberg LI, Brekke ML, Conn SA, Maxwell P, Brekke MJ. A controlled trial to integrate smoking cessation advice into primary care practice: Doctors helping smokers, round III. Journal of Family Practice. 1992;34(6).
  127. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee )ACIP). MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 1991;40)RR-13).
  128. Expanded Programme on Immunization : programme report for the year 1992, incorporating the recommendations of the Global Advisory Group, October 1992. 1993.
  129. Blaine Hollinger F. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. The American Journal of Medicine. 1989;87)3 SUPPL. 1).
  130. Hall AJ. Hepatitis B vaccination: Protection for how long and against what? Vol. 307, British Medical Journal. 1993.
  131. Bar-Shany S, Avitzur M, Tur-Kaspa R. Antibodies to hepatitis C in Israeli blood donors: age, sex and ethnic differences from HBsAg positive carriers. In: First Joint Spanish-Israeli Meeting on Liver and Biliary Disease. Jerusalem; 1992.
  132. Green MS, Block C, Slater PE. Rise in the incidence of viral hepatitis in israel despite improved socioeconomic conditions. Reviews of Infectious Diseases. 1989;11(3).
  133. Bogomolski-Yahalom V, Granot E, Linder N, Adler R, Korman S, Manny N, et al. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. Journal of Medical Virology. 1991;34(4).
  134. Peckham CS. Issues underlying the evaluation of screening programmes. Vol. 54, British Medical Bulletin. 1998.
  135. Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine. 1992;10)SUPPL. 1).
  136. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection Against Hepatitis A by an Inactivated Vaccine. JAMA: The Journal of the American Medical Association. 1994;271(17).
  137. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatric Infectious Disease Journal. 1993;12(5).
  138. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A Controlled Trial of a Formalin- Inactivated Hepatitis A Vaccine in Healthy Children. New England Journal of Medicine. 1992;327(7).
  139. Bancroft WH. Hepatitis A Vaccine. New England Journal of Medicine. 1992 Aug 13;327(7).
  140. Tormans G, van Damme P, van Doorslaer E. Cost-effectiveness analysis of hepatitis A prevention in travellers. Vaccine. 1992;10)SUPPL. 1).
  141. van Damme P, Cramm M, van der Auwera JC, Meheus A. Hepatitis A vaccination for health care workers. BMJ. 1993 Jun 12;306)6892).
  142. Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrrell H, Safary A, et al. Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. British Medical Journal. 1992;304)6837).
  143. Behrens RH, Roberts JA. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ. 1994;309)6959).
  144. Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Slepon R, et al. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. In: Israel Journal of Medical Sciences. 1994.
  145. Karetnyi Y v., Mendelson E, Shlyakhov E, Rubinstein E, Golubev N, Levin R, et al. Prevalence of antibodies against hepatitis A virus among new immigrants in Israel. Journal of Medical Virology. 1995;46(1).
  146. Ministry of Health I. Hepatitis A in Israel - 1993. Monthly Epidemiological Record. 1993.
  147. Bader TF. Hepatitis A vaccine. Am J Gastroenterol. 1996 Feb;91(2).
  148. Modan B, Shpilberg O, Anis E, Chetrit A, Luxenburg O, Rosenberg E, et al. The need for liver transplantation: a nationwide estimate based on consensus review. The Lancet. 1995;346)8976).
  149. Ackerman Z, Ablin J, Shouval D. Active immunization against hepatitis A is now warranted in glucose-6- phosphate dehydrogenase-deficient subjects ]12[. Vol. 91, American Journal of Gastroenterology. 1996.
  150. Krause DS. Hepatitis A Vaccines. JAMA: The Journal of the American Medical Association. 1996 Aug 14;276(6).
  151. Adler R, Shouval D. Hepatitis a prophylaxis vaccine or immunoglobulin? Clinical Immunotherapeutics. 1996;6(4).
  152. Bower C, Stanley FJ. Issues in the prevention of spina bifida. Vol. 89, Journal of the Royal Society of Medicine. 1996.
  153. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. British Medical Journal )Clinical research ed). 1981;282)6275).
  154. Milunsky A, Jick H, Jick SS, Bruell CL, Maclaughlin DS, Rothman KJ, et al. Multivitamin/Folic Acid Supplementation in Early Pregnancy Reduces the Prevalence of Neural Tube Defects. JAMA: The Journal of the American Medical Association. 1989;262)20).
  155. Swain RA, st. Clair L. The role of folic acid in deficiency states and prevention of disease. Vol. 44, Journal of Family Practice. 1997.
  156. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect. British Medical Journal. 1997;315)7112).
  157. Phillips AN, Wannamethee SG, Walker M, Thomson A, Smith GD. Life expectancy in men who have never smoked and those who have smoked continuously: 15 year follow up of large cohort of middle aged British men. British Medical Journal. 1996;313)7062).
  158. סלע ב. האם אנו מתקרבים לרגע האמת? הרפואה 131:524-30 ;1996
  159. Shaper AG, Wannamethee G, Walker M. Alcohol and coronary heart disease: A perspective from the British regional heart study. International Journal of Epidemiology. 1994;23(3).
  160. McDonald P, Friedman EHI, Banks A, Anderson R, Carman V. Pneumococcal vaccine campaign based in general practice. British Medical Journal. 1997;314)7087).
  161. בראון-אפל א, מגמות בתחלואה ובתמותה מסרטן בישראל 1995-1970. המרכז הלאומי לבקרת מחלות
  162. בריאות בישראל נתונים 3 :In .לוחות 6.13, 6.14 .editors ,אבורבה מ, עוזרי ר, גורדון ש, שטיין נ, מרציאנו א, חקלאי צ. .2001
  163. Wathen CN, MacMillan HL, Canadian Task Force on Preventive Health Care. Prevention of violence against women: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ. 2003 Sep 16;169(6).
  164. Rhodes K v., Levinson W. Interventions for Intimate Partner Violence Against Women: Clinical Applications. Vol. 289, Journal of the American Medical Association. 2003.
  165. Wathen CN, MacMillan HL. Interventions for Violence Against Women. JAMA. 2003 Feb 5;289(5).
  166. Krug EG, Mercy JA, Dahlberg LL et. al. World report on violence and health - World Health Organization. The Lancet. 2002;360.
  167. אלימות בין בני זוג: עמדת ההסתדרות הרפואית בישראל והנחיות לרופאים בדבר זיהוי וטיפול. ההסתדרות הרפואית בישראל, 2003
  168. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung Cancer Screening With Helical Computed Tomography in Older Adult Smokers. JAMA. 2003 Jan 15;289(3).
  169. Swensen SJ. Screening for cancer with computed tomography. BMJ. 2003 Apr 26;326)7395).
  170. Jorenby D. Clinical Efficacy of Bupropion in the Management of Smoking Cessation. Drugs. 2002;62)Supplement 2).
  171. Rigotti NA. Treatment of Tobacco Use and Dependence. New England Journal of Medicine. 2002 Feb 14;346(7).
  172. www.nice.org.uk.
  173. National Institute for Clinical excellence )NICE). Guidance on the use of nicotine replacement therapy )NRT( and bupropion for smoking cessation. Technology Appraisal Guidance . 2002;39.
  174. שטיינברג א, לוגר א, ממן ע, שטיינברג ש. השפעת העישון על מחלות אורתופדיות ותוצאות ניתוחים. הרפואה 2003;142)6(:442-5.
  175. Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. The Lancet. 2002 Oct;360)9339).
  176. משרד הבריאות. דו״ח שר הבריאות על העישון בישראל 2003-2002
  177. Burns D, Garfinkel L, Samet J. Changes in cigarette-related disease risks and their implication for prevention and control. NIH Publication 974213. U.S. Department of Health and Human Services, Public Health Service. National Institutes of Health, National Cancer Institute; 1997.
  178. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics. 1999;36(6).
  179. Burns D. Nicotine Addiction. In: Braunwald E, Hauser S, Fauci A, et al., editors. Harrison's Principles of Internal Medicine. 15th ed. McGraw Hill; 2001. p. 2574-7.
  180. Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000 Oct;45(10).
  181. Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating Tobacco Use and Dependence. Chest. 2002 Mar;121(3).
  182. Lieberman DA. Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals. JAMA. 2003 Dec 10;290(22).
  183. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Vol. 143, Annals of Internal Medicine. 2005.
  184. Maciosek M v., Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities Among Effective Clinical Preventive Services. Results of a Systematic Review and Analysis. American Journal of Preventive Medicine. 2006;31(1).
  185. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice )Constituted by representatives of nine societies and by invited experts). European Heart Journal. 2007 May 4;28(19).
  186. Barclay L, Vega C. Advantages and Disadvantages of Alcohol Intake on Cardiovascular Health Reviewed. Medscape.
  187. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM. Long-Term Follow-up of the West of Scotland Coronary Prevention Study. New England Journal of Medicine. 2007 Oct 11;357(15).
  188. שירותי בריאות כללית המלצות קליניות לאבחון וטיפול בדיכאון בקהילה .טבנקין ח, מוניץ ח, גולדפרכט מ, פלד ע, 2006
  189. Knoops KTB, de Groot LCPGM, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. J Am Med Assoc. 2004;292(12).
  190. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle. New England Journal of Medicine. 2000 Jul 6;343(1).
  191. גופנית - מרשם לבריאות], משרד הבריאות, 2005
  192. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease. Circulation. 2003;107)24).
  193. Pate RR. Physical Activity and Public Health-Reply. Vol. 274, JAMA: The Journal of the American Medical Association. 1995.
  194. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary Prevention of Ischemic Stroke. Stroke. 2006 Jun;37(6).
  195. Saris WHM, Blair SN, van Baak MA, Eaton SB, Davies PSW, di Pietro L, et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st stock conference and consensus statement. Vol. 4, Obesity Reviews. 2003.
  196. Lee C do, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. American Journal of Clinical Nutrition. 1999;69(3).
  197. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. Exercise and Hypertension. Medicine & Science in Sports & Exercise. 2004 Mar;36(3).
  198. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: Clinical and public health advisory from the National High Blood Pressure Education Program. J Am Med Assoc. 2002;288(15).
  199. Whelton SP, Chin A, Xin X, He J. Effect of Aerobic Exercise on Blood Pressure. Annals of Internal Medicine. 2002;136(7).
  200. Lee IM. Physical Activity and Cancer Prevention - Data from Epidemiologic Studies. In: Medicine and Science in Sports and Exercise. 2003.
  201. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera E v., et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2012 Jan;62(1).
  202. Strong WB, Malina RM, Blimkie CJR, Daniels SR, Dishman RK, Gutin B, et al. Evidence Based Physical Activity for School-age Youth. The Journal of Pediatrics. 2005 Jun;146(6).
  203. Twisk JWR. Physical activity guidelines for children and adolescents a critical review. Vol. 31, Sports Medicine. 2001.
  204. Strength Training by Children and Adolescents. PEDIATRICS. 2001 Jun 1;107(6).
  205. Epstein LH, Paluch RA, Kalakanis LE, Goldfield GS, Cerny FJ, Roemmich JN. How much activity do youth get? A quantitative review of heart-rate measured activity. Vol. 108, Pediatrics. 2001.
  206. Pivarnik JM, Chambliss HO, Clapp JF, Dugan SA, Hatch MC, Lovelady CA, et al. Impact of physical activity during pregnancy and postpartum on chronic disease risk. Vol. 38, Medicine and Science in Sports and Exercise. 2006.
  207. ACOG Committee Obstetric Practice. ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period. Obstet Gynecol. 2002;99(1).
  208. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Archives of Neurology. 2001;58(3).
  209. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women women who walk. Archives of Internal Medicine. 2001;161(14).
  210. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Annals of Internal Medicine. 2006;144(2).
  211. van Gelder BM, Tijhuis MAR, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D. Physical activity in relation to cognitive decline in elderly men: The FINE study. Neurology. 2004;63(12).
  212. Epstein EF. Leisure activities and the risk of dementia in the elderly: Comment. Vol. 349, The New England Journal of Medicine. 2003.
  213. Weuve J, Kang JH, Manson JAE, Breteler MMB, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. J Am Med Assoc. 2004;292(12).
  214. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurology. 2005;4(11).
  215. Deary IJ, Whalley LJ, Batty GD, Starr JM. Physical fitness and lifetime cognitive change. Neurology. 2006;67(7).
  216. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: A meta-analysis. Archives of Physical Medicine and Rehabilitation. 2004;85(10).
  217. Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: Systematic review and meta-analyses. Vol. 334, British Medical Journal. 2007.
  218. Mazzeo RS, Tanaka H. Exercise prescription for the elderly: Current recommendations. Vol. 31, Sports Medicine. 2001.
  219. van Sluijs EMF, McMinn AM, Griffin SJ. Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials. BMJ. 2007 Oct 6;335)7622).
  220. Young A, Dinan S. Activity in later life. BMJ. 2005 Jan 22;330)7484).
  221. משרד החינוך. תכנית לימודים בחינוך גופני לכיתות ג-יב. ירושלים 2007
  222. תכנית לימודים בחינוך גופני לגיל הרך — לגן הילדים ולכיתות א-ב. ירושלים, 2007
  223. Knutson KL, Spiegel K, Penev P, van Cauter E. The metabolic consequences of sleep deprivation. Vol. 11, Sleep Medicine Reviews. 2007.
  224. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14(6).
  225. National heart lung, and blood institute working group on insomnia. Insomnia: Assessment and Management in Primary Care. Am Fam Physician. 1999;59)11(:3029-38.
  226. van den Berg J, Neely G. Performance on a simple reaction time task while sleep deprived. Perceptual and Motor Skills. 2006;102(2).
  227. Kendall AP, Kautz MA, Russo MB, Killgore WDS. Effects of sleep deprivation on lateral visual attention. International Journal of Neuroscience. 2006;116(10).
  228. Killgore WDS, Balkin TJ, Wesensten NJ. Impaired decision making following 49 h of sleep deprivation. Journal of Sleep Research. 2006;15(1).
  229. Rajaratnam SMW, Arendt J. Health in a 24-h society. Vol. 358, Lancet. 2001.
  230. Connor J, Norton R, Ameratunga S, Robinson E, Civil I, Dunn R, et al. Driver sleepiness and risk of serious injury to car occupants: Population based case control study. British Medical Journal. 2002;324)7346).
  231. Belanger L, Morin CM, Langlois F, Ladouceur R. Insomnia and generalized anxiety disorder: Effects of cognitive behavior therapy for gad on insomnia symptoms. Journal of Anxiety Disorders. 2004;18(4).
  232. Brasic JR. Screening people with disturbed sleep for depression. Perceptual and Motor Skills. 2006;103(3).
  233. Ohayon MM, Lemoine P. Sleep and insomnia markers in the general population. Encephale. 2004;30(2).
  234. Slemenda C, Brandt KD, Heilman DK, Mazzuca S, Braunstein EM, Katz BP, et al. Quadriceps weakness and osteoarthritis of the knee. Annals of Internal Medicine. 1997;127(2).
  235. Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, et al. Meta-analysis: Chondroitin for osteoarthritis of the knee or hip. Vol. 146, Annals of Internal Medicine. 2007.
  236. Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: Network meta-analysis. BMJ )Online). 2010;341)7775).
  237. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: Findings from a national US sample. Annals of Family Medicine. 2010;8(1).
  238. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency. Archives of Internal Medicine. 2009;169(6).
  239. Lichtenberg D. ]Who is likely to gain from high dose supplementation of vitamin E?[. Harefuah. 2011;150(1).
  240. אייזיקוביץ' צ, ויטנרשטיין ט, לבנשטיין א. סקר התעללות והזנחה של זקנים בישראל. אוניברסיטת חיפה, המרכז לחקר ולימוד הזיקנה, אש"ל וביטוח לאומי, 2004
  241. אלמגור-לוטן א. אלימות נגד נשים: ריכוז נתונים לשנת 2011. הוועדה לקידום מעמד האישה, הכנסת, 2011
  242. המועצה הלאומית לשלום הילד. פרקים 13 ו-14. In: לקט נתונים מתוך השנתון ילדים בישראל, 2011
  243. איתור זיהוי וטיפול בקטינים נפגעי התעללות והזנחה - חוזר משרד הבריאות
  244. איתור וטיפול נשים נפגעות אלימות במשפחה ע"י מטפלים - חוזר משרד הבריאות
  245. משרד הבריאות. מינוי ועדות קבועות לנושא אלימות במשפחה, ניצול מיני והזנחה של קטינים וחסרי ישע, 2003.
  246. משרד הבריאות. חובת יידוע. חוזר 01/2003
  247. משרד הבריאות. נוהל טיפול בנפגעי/עות תקיפה מינית, 2003
  248. העברת מידע בין מוסדות רפואיים לאיתור וזיהוי קטינים וחסרי ישע נפגעי אלימות במשפחה 1 - חוזר משרד הבריאות
  249. נוהל טיפול בזקנים נפגעי התעמרות - חוזר משרד הבריאות
  250. לוי ש. התעללות בקשישים והזנחת קשישים בישראל: נתונים ודרכי התמודדות. מרכז המידע של הכנסת, 2006
  251. ראביד ג. זה בידיים שלנו: ניתוח תחום מניעת אלימות נגד נשים, 2010
  252. שטינמץ ד, טבנקין ח. אלימות במשפחה: שכיחות התופעה בקרב מטופלים המבקרים במרפאתם הראשונית. הרפואה. 2008;147)12(:978-85.
  253. Campbell JC. Health consequences of intimate partner violence. Vol. 359, Lancet. 2002.
  254. Eisikovits Z, Winstok Z, Fishman G. The first Israeli national survey on domestic violence. Vol. 10, Violence Against Women. 2004.
  255. Feder G, Ramsay J, Dunne D, Rose M, Arsene C, Norman R, et al. How far does screening women for domestic )partner( violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK, National Screening Committee critieria. Vol. 13, Health Technology Assessment. 2009.
  256. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults. American Journal of Preventive Medicine. 1998 May;14(4).
  257. Garcia-Moreno C, Watts C. Violence against women: An urgent public health priority. Vol. 89, Bulletin of the World Health Organization. 2011.
  258. Grynbaum M, Biderman A, Levy A, Petasne-Weinstock S. Domestic violence: Prevalence among women in a primary care center - A pilot study. Israel Medical Association Journal. 2001;3(12).
  259. Screening for Family and Intimate Partner Violence: Recommendation Statement. Vol. 140, Annals of Internal Medicine. 2004.
  260. Nelson HD, Nygren P, McInerney Y, Klein J. Screening Women and Elderly Adults for Family and Intimate Partner Violence: A Review of the Evidence for the U.S. Preventive Services Task Force. Vol. 140, Annals of Internal Medicine. 2004.
  261. O'Campo P, Kirst M, Tsamis C, Chambers C, Ahmad F. Implementing successful intimate partner violence screening programs in health care settings: Evidence generated from a realist-informed systematic review. Social Science and Medicine. 2011;72(6).
  262. Schein M, Biderman A, Baras M, Bennett L, Bisharat B, Borkan J, et al. The prevalence of a history of child sexual abuse among adults visiting family practitioners in Israel. Child Abuse and Neglect. 2000;24(5).
  263. Taket A, Wathen CN, MacMillan H. Should health professionals screen all women for domestic violence? Vol. 1, PLoS Medicine. 2004.
  264. WHO - Expert meeting on Health-sector responses to violence against women. In Geneva; 2009.
  265. WHO Multi-country Study on Women's Health and Domestic Violence against Women. In 2005.
  266. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine. 2011 Aug 4;365(5).
  267. U.S preventive Services task force. U.S preventive Services task force recommendation 2012.
  268. Krumholz HM, Seeman TE, Merrill SS, Leon CFM, Vaccarino V, Silverman DI, et al. Lack of Association Between Cholesterol and Coronary Heart Disease Mortality and Morbidity and All-Cause Mortality in Persons Older Than 70 Years. JAMA: The Journal of the American Medical Association. 1994;272(17).
  269. Summary of current guidelines for the cancer-related checkup: recommendation. New York: American Cancer Society; 1988.
  270. Triezenberg DJ, Smith MA, Holmes TM. Cancer screening and detection in family practice: A MIRNET study. Journal of Family Practice. 1995;40(1).
  271. Austoker J. Screening and self examination for breast cancer. Vol. 309, British Medical Journal. 1994.
  272. Jatoi I, Baum M. American and European recommendations for screening mammography in younger women: A cultural divide? Vol. 307, British Medical Journal. 1993.
  273. Shapiro S, Venet W, Strax P, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69(2).
  274. Wright CJ, Mueller CB. Screening mammography and public health policy: the need for perspective. The Lancet. 1995;346)8966).
  275. Austoker J. Cancer Prevention in Primary Care Screening for colorectal cancer. BMJ. 1994 Aug 6;309)6951).
  276. Winawer SJ, St John DJ, Bond JH, Rozen P, Burt RW, Waye JD, et al. Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ. 1995;73(1).
  277. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. New England Journal of Medicine. 1993;328(19).
  278. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A Comparison of Fecal Occult-Blood Tests for Colorectal- Cancer Screening. New England Journal of Medicine. 1996;334(3).
  279. Potshuma WFM, Westendorp RGJ, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: Is the evidence biased? BMJ. 1994;308)6939).
  280. Grady D, Cummings SR, Petitti D, Rubin SM, Audet AM, Sox HC, et al. Guidelines for counseling postmenopausal women about preventive hormone therapy. Annals of Internal Medicine. 1992;117(12).
  281. Wood AJJ, Belchetz PE. Hormonal Treatment of Postmenopausal Women. New England Journal of Medicine. 1994;330(15).
  282. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Vol. 117, Annals of Internal Medicine. 1992.
  283. Wood AJJ, Riggs BL, Melton LJ. The Prevention and Treatment of Osteoporosis. New England Journal of Medicine. 1992 Aug 27;327(9).
  284. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. New England Journal of Medicine. 1995;332)24).
  285. רוזנפלד, קיצס-כהן, גולדשמיד. יתרונות וחסרונות הטיפול ההורמונלי התחליפי: עדכון. תרפיה שימושית, 1994
  286. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc. 1998;280(7).
  287. Sidney S, Petitti DB, Quesenberry CP. Myocardial infarction and the use of estrogen and estrogen- progestogen in postmenopausal women. Annals of Internal Medicine. 1997;127(7).
  288. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, et al. Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women. New England Journal of Medicine. 1997;337(23).
  289. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, et al. Postmenopausal Hormone Therapy and Mortality. Obstetrical & Gynecological Survey. 1997;52(11).
  290. Whitehead M. Treatments for menopausal and post-menopausal problems: Present and future. Bailliere's Clinical Obstetrics and Gynaecology. 1996;10(3).
  291. Barrett-Connor E. Fortnightly review: Hormone replacement therapy. BMJ. 1998;317)7156).
  292. Harris R. Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2002 Dec 3;137(11).
  293. Lu-Yao G. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002 Oct 5;325)7367).
  294. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, et al. A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer. New England Journal of Medicine. 2002 Sep 12;347(11).
  295. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The Influence of Finasteride on the Development of Prostate Cancer. New England Journal of Medicine. 2003 Jul 17;349(3).
  296. Frankel S, Smith GD, Donovan J, Neal D. Screening for prostate cancer. The Lancet. 2003 Mar;361)9363).
  297. Schroeder BM, American Cancer Society. ACS updates guideline for the early detection of cervical neoplasia and cancer. American Cancer Society. Am Fam Physician. 2003 May 1;67(9).
  298. Mahoney MC, Saslow D, Cohen CJ, ACS. ACS guideline for the early detection of cervical cancer. Am Fam Physician. 2003 Apr 15;67(8).
  299. U.S. Preventive Services Task Force. Screening for Cervical Cancer: Recommendations and Rationale. American Family Physician. 2003;67)8(:1759-66.
  300. בורנשטיין י, אברמוביץ ח. חשיבות ביצוע סריקה המונית לגילוי מוקדם של סרטן צוואר הרחם במדינת ישראל. הרפואה .176-80:)12(122;1992
  301. סטרול ח, אליקים ר, הלפרן ז, ארבר נ. מניעה וגילוי מוקדם של סרטן הכרכשת בכלל האוכלוסיה: יום עיון וסיכום עמדת האיגוד לגסטרואנטרולוגיה. הרפואה 142:223-6;2003 .
  302. Walsh JME, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003 Mar 12;289(10).
  303. Sonnenberg A, Delco F Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002 Jan 28;162(2).
  304. Boyle P. Faecal occult blood testing )FOBT( as screening for colorectal cancer: the current controversy. Annals of Oncology. 2002 Jan;13(1).
  305. Detsky AS. Screening for Colon Cancer — Can We Afford Colonoscopy? New England Journal of Medicine. 2001 Aug 23;345(8).
  306. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002 Jun 6;346(23).
  307. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed Tomographic Virtual Colonoscopy to Screen for Colorectal Neoplasia in Asymptomatic Adults. New England Journal of Medicine. 2003 Dec 4;349(23).
  308. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002 Nov 7;347(19).
  309. Tall AR. Exercise to Reduce Cardiovascular Risk — How Much Is Enough? New England Journal of Medicine. 2002;347(19).
  310. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. J Am Med Assoc. 2003;289(2).
  311. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. New England Journal of Medicine. 2003;348(17).
  312. מניעה וטיפול בהשמנת ילדים ובני נוער - הנחייה קלינית
  313. Estabrooks PA, Glasgow RE, Dzewaltowski DA. Physical Activity Promotion Through Primary Care. Vol. 289, Journal of the American Medical Association. 2003.
  314. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Vol. 360, Lancet. 2002.
  315. Chobanian A v., Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. Vol. 289, Journal of the American Medical Association. 2003.
  316. Elley CR, Kerse N, Arroll B, Robinson E. Effectiveness of counselling patients on physical activity in general practice: Cluster randomised controlled trial. British Medical Journal. 2003;326)7393).
  317. פעילות גופנית במסגרת מניעתה הראשונית של מחלת הלב הכלילית - נייר עמדה
  318. Hermansen K, Dinesen B, Hoie LH, Morgenstern E, Gruenwald J. Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: A literature review. Vol. 20, Advances in Therapy. 2003.
  319. LaRosa JC. Understanding risk in hypercholesterolemia. Vol. 26, Clinical Cardiology. 2003.
  320. Shepherd J, Gaw A. The Anatomy of a Clinical Trial. Medical Principles and Practice. 2002;11(2).
  321. Zanchetti A. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Vol. 21, Journal of Hypertension. 2003.
  322. Chobanian A v., Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Vol. 42, Hypertension. 2003.
  323. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/ TexCAPS. J Am Med Assoc. 1998;279)20).
  324. Lewis S, Sacks F, Mitchell J, East C, Glasser S, Kell S, et al. Effect of Pravastatin on Cardiovascular Events in Women After Myocardial Infarction: The Cholesterol and Recurrent Events )CARE( Trial. J Am Coll Cardiol. 1998;32:140-6.
  325. חרץ ד, רובינשטיין א. הנחיות והמלצות בנושא טיפול ומניעה של מחלת לב כלילית וטרשת עורקים. ההסתדרות הרפואית בישראל והאגף לאבטחת איכות 1999
  326. צבעוני ד. מניעה ראשונית של מחלת. לב כלילית וכלי דם באוכלוסיה הבוגרת. המועצה הלאומית למניעת מחלות לב. 2003.
  327. Prevention and control of non-communicable diseases. In: Fifty-fifth World Health Assembly. Geneva: World Health Organization; 2002. p. 28-30.
  328. Puska P, Vartiainen E, Tuomilehto J, Salomaa V, Nissinen A. Changes in premature deaths in Finland: Successful long-term prevention of cardiovascular diseases. Bull World Health Organ. 1998;76(4).
  329. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. 2007.
  330. Stubbs J, Ferres S, Horgan G. Energy density of foods: Effects on energy intake. Critical Reviews in Food Science and Nutrition. 2000;40(6).
  331. Rolls BJ, Bell EA. Dietary approaches to the treatment of obesity. Medical Clinics of North America. 2000;84(2).
  332. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: Need to focus on high risk abdominally obese patients. Vol. 322, British Medical Journal. 2001.
  333. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine. 2001;344(18).
  334. Mann J. Dietary fibre and diabetes revisited. European Journal of Clinical Nutrition. 2001;55(11).
  335. Oomen CM, Ocke MC, Feskens EJM, van Erp-Baart MAJ, Kok FJ, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: A prospective population-based study. Lancet. 2001;357)9258).
  336. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension )DASH( Diet. New England Journal of Medicine. 2001;344(1).
  337. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, et al. EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL )DART). The Lancet. 1989;334)8666).
  338. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, et al. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies. Vol. 285, Journal of the American Medical Association. 2001.
  339. Nitzan Kaluski D, Leventhal A, Averbuch Y, Rishpon S, Cohen-Dar M, Habib S, et al. Five decades of trends in anemia in Israeli infants: Implications for food fortification policy. European Journal of Clinical Nutrition. 2001;55(2).
  340. Kaluski DN, Chinich A, Leventhal A, Ifrah A, Cohen-Mannheim I, Merom D, et al. Overweight, stature, and socioeconomic status among women - Cause or effect: Israel national women's health interview survey, 1998. Journal of Gender-Specific Medicine. 2001;4(4).
  341. Steptoe A, Perkins-Porras L, McKay C, Rink E, Hilton S, Cappuccio FP. Behavioural counselling to increase consumption of fruit and vegetables in low income adults: Randomised trial. British Medical Journal. 2003;326)7394).
  342. Miller AB. Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years. J Natl Cancer Inst. 2000 Sep 20;92(18).
  343. Ringash J, Canadian Task Force on Preventive Health Care. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ. 2001 Feb 20;164(4).
  344. G0tzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000 Jan 8;355)9198).
  345. Olsen O, G0tzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358)9290).
  346. Goodare H, Dimmer C, Page K. Screening mammography: setting the record straight. Lancet. 2002 Feb 2;359)9304).
  347. Horton R. Screening mammography--an overview revisited. Lancet. 2001 Oct 20;358)9290).
  348. Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF. Mammographic screening: no reliable supporting evidence? Lancet. 2002 Feb 2;359)9304).
  349. Tabar L, Smith RA, Duffy SW. Update on effects of screening mammography. The Lancet. 2002 Jul;360)9329).
  350. Tabar L, Yen MF, Vitak B, Chen HHT, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003 Apr 26;361)9367).
  351. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 Sep 3;137)5 Part 1).
  352. Berg AO. Screening for breast cancer: Recommendations and rationale. Vol. 65, American Family Physician. 2002.
  353. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van't Veer L, Garber JE, et al. Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations. New England Journal of Medicine. 2002 May 23;346)21).
  354. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001 Jul 19;345(3).
  355. Thomas DB, Self SG, Allison CJ, Tao Y, Mahloch J, Ray R, et al. Randomized Trial of Breast self-examination in Shanghai: Methodology and Preliminary Results. JNCI Journal of the National Cancer Institute. 1997 Mar 5;89(5).
  356. Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Nomura Y, et al. Tamoxifen for early breast cancer: An overview of the randomised trials. The Lancet. 1998;351)9114).
  357. John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiologic Reviews. 1993;15(1).
  358. אלוייס ת, ניסן א, שפירא ר, סקלייר-לוי מ, פרוינד ה, פרץ ת. ממוגרפיה סוקרת לאיבחון מוקדם של סרטן השד: העובדות, המחלוקות והיישום בישראל. הרפואה. 2003;142:281-6
  359. Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: The OFELY study. Journal of Bone and Mineral Research. 2005;20(10).
  360. Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Archives of Internal Medicine. 2004;164(10).
  361. van der Klift M, de Laet CEDH, McCloskey E v., Hofman A, Pols HAP. The incidence of vertebral fractures in men and women: The Rotterdam study. Journal of Bone and Mineral Research. 2002;17(6).
  362. Khosla S, Melton LJ. clinical practice Osteopenia. Vol. 356, N Engl J Med. 2007.
  363. Martyn-St. James M, Carroll S. High-intensity resistance training and postmenopausal bone loss: A meta-analysis. Osteoporosis International. 2006;17(8).
  364. Palombaro KM. Effects of walking-only interventions on bone mineral density at various skeletal sites: a meta-analysis. J Geriatr Phys Ther. 2005;28(3).
  365. Kanis JA, Johnell O, Black DM, Downs RW, Sarkar S, Fuerst T, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: A reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone. 2003;33(3).
  366. Martino S, Cauley JA, Barrett-Connor E, Powles TJ, Mershon J, Disch D, et al. Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst. 2004;96(23).
  367. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, et al. Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women. New England Journal of Medicine. 2004;350(12).
  368. Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, et al. Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis. Calcified Tissue International. 2004 Apr 1;74(2).
  369. Rosen CJ, Hochberg MC, Bonnick SL, McClung M, Miller P, Broy S, et al. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study. Journal of Bone and Mineral Research. 2005;20(1).
  370. Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate )REAL( cohort study. Osteoporosis International. 2007;18(1).
  371. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. New England Journal of Medicine. 2007;356(18).
  372. Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, et al. Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density. New England Journal of Medicine. 2002;346(9).
  373. Graham L. NAMS releases updated position statement on the use of estrogen and progestogen in perimenopausal and postmenopausal women. Vol. 76, American Family Physician. 2007.
  374. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The Decrease in Breast-Cancer Incidence in 2003 in the United States. New England Journal of Medicine. 2007;356(16).
  375. Beral V. Ovarian cancer and hormone replacement therapy in the Million Women Study. The Lancet. 2007 May;369)9574).
  376. Roberts H. Managing the menopause. BMJ. 2007 Apr 7;334)7596).
  377. Long term hormone replacement therapy with estradiol alone is linked to breast cancer. BMJ. 2007;334)7583).
  378. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstetrics and Gynecology. 2006;108(6).
  379. Harris R. Screening for breast cancer: what to do with the evidence. Am Fam Physician. 2007;75)11(:1623-6.
  380. Buzdar AU. Dietary modification and risk of breast cancer. Vol. 295, Journal of the American Medical Association. 2006.
  381. Trock BJ, Leena HC, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98(7).
  382. Bernstein L, Patel A v., Ursin G, Sullivan-Halley J, Press MF, Deapen D, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst. 2005;97(22).
  383. Coombs NJ, Taylor R, Wilcken N, Boyages J. Hormone replacement therapy and breast cancer: Estimate of risk. Vol. 331, British Medical Journal. 2005.
  384. Chen WY, Manson JAE, Hankinson SE, Rosner B, Holmes MD, Willett WC, et al. Unopposed estrogen therapy and the risk of invasive breast cancer. Archives of Internal Medicine. 2006;166(9).
  385. Beral V, Bull D, Doll R, Peto R, Reeves G. Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet. 2002;360)9328).
  386. Lie JAS, Roessink J, Kj^rheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes and Control. 2006;17(1).
  387. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, et al. Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women. New England Journal of Medicine. 2006;355(2).
  388. Gradishar WJ, Cella D. Selective estrogen receptor modulators and prevention of invasive breast cancer. Vol. 295, Journal of the American Medical Association. 2006.
  389. Dixon JM. Screening for breast cancer. BMJ. 2006 Mar 4;332)7540).
  390. Irwig L, Houssami N, Armstrong B, Glasziou P. Evaluating new screening tests for breast cancer. Vol. 332, British Medical Journal. 2006.
  391. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. Journal of Clinical Oncology. 2005;23)33).
  392. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene )STAR( P-2 trial. J Am Med Assoc. 2006;295(23).
  393. Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee M, et al. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene )STAR( P-2 trial. J Am Med Assoc. 2006;295(23).
  394. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368)9552).
  395. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. In: Mayo Clinic Proceedings. 2007.
  396. van Nagell JR, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer. 2007 May 1;109(9).
  397. Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol. 2005 Nov 1;23)31).
  398. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, et al. A Randomized Trial of Aspirin to Prevent Colorectal Adenomas. New England Journal of Medicine. 2003;348(10).
  399. Beresford SAA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, et al. Low-Fat Dietary Pattern and Risk of Colorectal Cancer. JAMA. 2006;295(6).
  400. Bresalier RS, Sandler RS, Quan H, Bolognese J a, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. Adenomatous Polyp Prevention on Vioxx )APPROVe( Trial Investigators. The New England Jourmal of Medicine. 2005;352(11).
  401. Davies RJ, Miller R, Coleman N. Colorectal cancer screening: Prospects for molecular stool analysis. Vol. 5, Nature Reviews Cancer. 2005.
  402. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: Computed tomographic colonography. Vol. 142, Annals of Internal Medicine. 2005.
  403. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91(5).
  404. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer. New England Journal of Medicine. 2000;343(22).
  405. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut. 2002;50(1).
  406. Rennert G, Rennert HS, Miron E, Peterburg Y. Population colorectal cancer screening with fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11).
  407. Rennert G. Dietary intervention studies and cancer prevention. Vol. 11, European Journal of Cancer Prevention. 2002.
  408. Rennert G. Fecal Occult Blood Screening — Trial Evidence, Practice and Beyond. In 2003.
  409. Rennert G. Diet and cancer: where are we and where are we going? Proceedings of the Nutrition Society. 2003;62(1).
  410. Poynter JN, Gruber SB, Higgins PDR, Almog R, Bonner JD, Rennert HS, et al. Statins and the Risk of Colorectal Cancer. New England Journal of Medicine. 2005;352)21).
  411. Brenner DE, Rennert G. Fecal DNA biomarkers for the detection of colorectal neoplasia: Attractive, but is it feasible? Vol. 97, Journal of the National Cancer Institute. 2005.
  412. Rennert G, Almog R, Tomsho LP, Low M, Pinchev M, Chaiter Y, et al. Colorectal polyps in carriers of the APC I1307K polymorphism. Diseases of the Colon and Rectum. 2005;48(12).
  413. Rennert G, Kislitsin D, Brenner DE, Rennert HS, Lev Z. Detecting K-ras mutations in stool from fecal occult blood test cards in multiphasic screening for colorectal cancer. Cancer Lett. 2007 Aug 18;253(2).
  414. Rennert G. Prevention and early detection of colorectal cancer--new horizons. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2007;174.
  415. Boggs BD, Stephens MM, Wallace R. How does colonoscopy compare with fecal occult blood testing as a screening tool for colon cancer? Vol. 54, Journal of Family Practice. 2005.
  416. Survival of Patients with Stage I Lung Cancer Detected on CT Screening. New England Journal of Medicine. 2006;355(17).
  417. Ganti AK, Mulshine JL. Lung cancer screening: Panacea or pipe dream? Annals of Oncology. 2005;16)SUPPL. 2).
  418. Gleeson F v. Is screening for lung cancer using low dose spiral CT scanning worthwhile? Vol. 61, Thorax. 2006.
  419. Ilic D, O'Connor D, Green S, Wilt TJ. Screening for prostate cancer. In: Ilic D, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2006.
  420. Roobol MJ, Grenabo A, Schroder FH, Hugosson J. Interval cancers in prostate cancer screening: Comparing 2- and 4-year screening intervals in the European randomized study of screening for prostate cancer, Gothenburg and Rotterdam. J Natl Cancer Inst. 2007;99(17).
  421. פת י. אספירין, האמנם טיפול אידיאלי. כתב העת הישראלי לרפואת המשפחה .8-14:)103(16;2006
  422. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials. Vol. 295, Journal of the American Medical Association. 2006.
  423. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A Randomized Trial of Low- Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women. New England Journal of Medicine. 2005;352(13).
  424. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. Vol. 297, Journal of the American Medical Association. 2007.
  425. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Vol. 142, Annals of Internal Medicine. 2005.
  426. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. Vol. 293, Journal of the American Medical Association. 2005.
  427. Bruinooge SS. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. Vol. 21, Journal of Clinical Oncology. 2003.
  428. בדיקות גנטיות - בדיקות BRCA2 ,BRCA1
  429. משרד הבריאות. מניעה וגילוי מוקדם של מחלות סרטן 2005
  430. Insomnia: assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia. Am Fam Physician. 1999 Jun;59(11).
  431. Jankowski J, Boulton E. Cancer prevention. BMJ. 2005 Sep 17;331)7517).
  432. U.S. Preventive task force Guide to Clinical Preventive Services. Updates 2006-2007.
  433. National Comprehensive Cancer Guidelines. NCCN Guidelines.
  434. Peshkin , BN, Isaacs C. Overview of hereditary breast and ovarian cancer syndromes associated with genes other than BRCA1/2.
  435. Ojha S, Laslett N. Hereditary Nonpolyposis Colon Cancer. StatPearls. 2020;
  436. Carr S, Kasi A. Familial Adenomatous Polyposis. StatPearls. 2021;
  437. van Leeuwaarde R, Ahmad S, Links T, Giles R. Von Hippel-Lindau Syndrome. GeneReviews. 2000;
  438. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008 May 6;148(9).
  439. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002 Feb 7;346(6).
  440. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: Meta-analysis. BMJ. 2008;337)7671).
  441. Hite AH. Is the science behind the 2010 Dietary Guidelines for Americans " unquestioned?" Vol. 27, Nutrition. 2011.
  442. Rowe S, Alexander N, Almeida NG, Black R, Burns R, Bush L, et al. Translating the Dietary Guidelines for Americans 2010 to Bring about Real Behavior Change. J Am Diet Assoc. 2011;111(1).
  443. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans. 2nd ed. Washington DC; 2018.
  444. זלר ל, סוקניק ש. הקשר שבין עיסוק בספורט לבין התפתחות אוסטאוארתריטיס של הברכיים. הרפואה 315-9:(4)147;2008
  445. ישראל. חוק מכוני כושר (רישוי ופיקוח), 1994. ספר החוקים 1988
  446. ישראל. חוק הספורט, התשמ"ח-1988
  447. Thompson W, Gordon N, Pescatello L. ACSM's Guidelines for Exercise Testing and Prescription. Baltimore: Lippincott Williams & Wilkins; 2010.
  448. מרום-קליבנסקי ר, שיינוביץ מ, גולדבורט א, דנקנר ר, שטרסברג ב. הנחיות קליניות: הבדיקות הנדרשות בטרם יוחל בפעילות גופנית לא תחרותית באוכלוסיה הבוגרת בישראל. ההסתדרות הרפואית בישראל 2005
  449. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update. Circulation. 2007;115(12).
  450. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Vol. 116, Circulation. 2007.
  451. Bernhardt D, Roberts W. Preparticipation Physical Evaluation. 4th ed. American Academy of Pediatrics; 2010.
  452. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, et al. Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: Position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Vol. 18, European Journal of Cardiovascular Prevention and Rehabilitation. 2011.
  453. Corrado D, Biffi A, Basso C, Pelliccia A, Thiene G. 12-lead ECG in the athlete: Physiological versus pathological abnormalities. Vol. 43, British Journal of Sports Medicine. 2009.
  454. Harpaz R, Hales CM, Bialek SR. Update on herpes zoster vaccine: Licensure for persons aged 50 through 59 years. Morbidity and Mortality Weekly Report. 2011;60)44).
  455. Lu PJ, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. American Journal of Preventive Medicine. 2011;40(2).
  456. Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA - Journal of the American Medical Association. 2011;305(2).
  457. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study. CMAJ. 2010;182(16).
  458. Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. British Journal of Cancer. 2011;105.
  459. מניעה וגילוי מוקדם של מחלות ממאירות - חוזר מנכ"ל - Malignancy prevention and early detection
  460. USPSTF. A-Z Topic Guide.
  461. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet. 2008;371)9626).
  462. Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010 Sep 14;341)sep14 1).
  463. Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, et al. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2011 Dec 6;155(11).
  464. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Mortality Results from a Randomized Prostate-Cancer Screening Trial. New England Journal of Medicine. 2009 Mar 26;360(13).
  465. Schroder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. Screening and Prostate-Cancer Mortality in a Randomized European Study. New England Journal of Medicine. 2009;360(13).
  466. Gulati R, Mariotto AB, Chen S, Gore JL, Etzioni R. Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates. Journal of Clinical Epidemiology. 2011;64(12).
  467. Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, et al. Screening for prostate cancer: The current evidence and guidelines controversy. Vol. 18, Canadian Journal of Urology. 2011.
  468. Sandblom G, Varenhorst E, Rosell J, Lofman O, Carlsson P. Random is ed prostate cancer screening trial: 20 Year follow-up. BMJ. 2011;342)7803).
  469. Schroder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. Prostate-Cancer Mortality at 11 Years of Follow-up. New England Journal of Medicine. 2012;366(11).
  470. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104(2).
  471. Buys SS. Effect of Screening on Ovarian Cancer Mortality. JAMA. 2011;305(22).
  472. Beral V. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet. 2007;369)9574).
  473. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011 Jul 28;343.
  474. Kalager M, Zelen M, Langmark F, Adami HO. Effect of Screening Mammography on Breast-Cancer Mortality in Norway. New England Journal of Medicine. 2010 Sep 23;363(13).
  475. Welch HG, Frankel BA. Likelihood that a woman with screen-detected breast cancer has had her "life saved" by that screening. Arch Intern Med. 2011 Dec 12;171(22).
  476. Welch HG. Screening Mammography — A Long Run for a Short Slide? New England Journal of Medicine. 2010 Sep 23;363(13).
  477. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. New England Journal of Medicine. 2012 Feb 23;366(8).
  478. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths. New England Journal of Medicine. 2012 Feb 23;366(8).
  479. Niv Y. ]Colonoscopy for early detection and prevention of colorectal cancer[. Harefuah. 2010 Aug;149(8).
  480. Cuzick J, DeCensi A, Arun B, Brown PH, Castiglione M, Dunn B, et al. Preventive therapy for breast cancer: a consensus statement. Lancet Oncol. 2011 May;12(5).
  481. U.S preventive services task force. Counseling and Interventions to Prevent Tobacco Use and Tobacco- Caused Disease in Adults and Pregnant Women: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. Annals of Internal Medicine. 2009 Apr 21;150(8).
  482. שירותי בריאות כללית. המלצות מקצועיות להתערבות ראשונית לגמילה מעישון לצוות המרפאה
  483. Nelson HD, Walker M, Zakher B, Mitchell J. Menopausal hormone therapy for the primary prevention of chronic conditions: A systematic review to update the U.S. preventive services task force recommendations. Vol. 157, Annals of Internal Medicine. 2012.
  484. LaCroix AZ, Chlebowski RT, Manson JAE, Aragaki AK, Johnson KC, Martin L, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial. JAMA - Journal of the American Medical Association. 2011;305(13).
  485. Beral V, Reeves G, Bull D, Green J. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst. 2011;103(4).
  486. Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA - Journal of the American Medical Association. 2010;304(15).
  487. Ray KK, Seshasai SRK, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins and all-cause mortality in high- risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65 229 participants. Vol. 170, Archives of Internal Medicine. 2010.
  488. USPSTF. Screening for Lipid Disorders in Adults : Recommendation Statement. Am Fam Physician. 2009;80(11).
  489. Hughes S. Cochrane Review Stirs Controversy Over Statins in Primary Prevention. Medscape. 2011.
  490. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based Use of Statins for Primary Prevention of Cardiovascular Disease. The American Journal of Medicine. 2012 May;125(5).
  491. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women: The framingham study. Annals of Internal Medicine. 1992;116(7).
  492. Bartolucci AA, Tendera M, Howard G. Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. In: American Journal of Cardiology. 2011.
  493. Raju N, Sobieraj-Teague M, Hirsh J, O'Donnell M, Eikelboom J. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. American Journal of Medicine. 2011;124(7).
  494. Arendt J. Managing jet lag: Some of the problems and possible new solutions. Vol. 13, Sleep Medicine Reviews. 2009.
  495. Varughese J, Allen RP. Fatal accidents following changes in daylight savings time: The American experience. Sleep Medicine. 2001;2(1).
  496. Sack RL. Jet Lag. New England Journal of Medicine. 2010 Feb 4;362(5).
  497. Silverman D, Gendreau M. Medical issues associated with commercial flights. Vol. 373, The Lancet. 2009.
  498. de Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V leiden: Clinical implications. Vol. 24, Seminars in Thrombosis and Hemostasis. 1998.
  499. Kim S, Palin F, Anderson P, Edwards S, Lindner G, Rothbaum BO. Use of skills learned in CBT for fear of flying: Managing flying anxiety after September 11th. Journal of Anxiety Disorders. 2008;22(2).
  500. Bor R. Psychological factors in airline passenger and crew behaviour: A clinical overview. Travel Medicine and Infectious Disease. 2007;5(4).
  501. Bor R. Trends in disruptive passenger behaviour on board UK registered aircraft: 1999-2003. Travel Medicine and Infectious Disease. 2003;1(3).
  502. Estrada A, LeDuc PA, Curry IP, Phelps SE, Fuller DR. Airsickness prevention in helicopter passengers. Aviation Space and Environmental Medicine. 2007;78)4 I).
  503. Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ. Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines )8th edition). Chest. 2008;133)6 SUPPL. 6).
  504. Chandra D, Parisini E, Mozaffarian D. Meta-analysis: Travel and risk for venous thromboembolism. Vol. 151, Annals of Internal Medicine. 2009.
  505. Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2011 Mar 1;154(5).
  506. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults: The Adverse Childhood Experiences )ACE(Study. American Journal of Preventive Medicine. 2019;56(6).
  507. MacMillan HL, Wathen CN, Jamieson E, Boyle MH, Shannon HS, Ford-Gilboe M, et al. Screening for intimate partner violence in health care settings: A randomized trial. JAMA - Journal of the American Medical Association. 2009;302(5).
  508. יעקובסון י. דו"ח הועדה המייעצת לרופא הראשי של שירותי בריאות כללית בנושא מדדי איכות ברפואת המשפחה. 2010 ;שירותי בריאות כללית
  509. US Preventive Services Task Force. Chronic Kidney Disease: Screening: Final Recommendation Statement. 2012.
  510. Fowkes FGR. Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index<subtitle>A Randomized Controlled Trial</subtitle> JAMA. 2010 Mar 3;303)9(:841.
  511. Israel Center for Disease Control and MOH Department of Health Promotion and Education. KAP survey. 2007.
  512. Ojo O, Ojo O, Adebowale F, Wang XH. The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018 Mar 19;10(3).
  513. Anton S, Hida A, Heekin K, Sowalsky K, Karabetian C, Mutchie H, et al. Effects of Popular Diets without Specific Calorie Targets on Weight Loss Outcomes: Systematic Review of Findings from Clinical Trials. Nutrients. 2017 Jul 31;9(8).
  514. Andrade AM, Greene GW, Melanson KJ. Eating Slowly Led to Decreases in Energy Intake within Meals in Healthy Women. J Am Diet Assoc. 2008;108(7).
  515. LeBlanc ES, Patnode CD, Webber EM, Redmond N, Rushkin M, O'Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults updated evidence report and systematic review for the US preventive services task force. Vol. 320, JAMA - Journal of the American Medical Association. 2018.
  516. Patnode CD, Evans C v., Senger CA, Redmond N, Lin JS. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention inadultswithout knowncardiovascular disease risk factors: Updated evidence report and systematic review for the US preventive services task force. Vol. 318, JAMA - Journal of the American Medical Association. 2017.
  517. U.S. Preventive Services Task Force. Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions. 2018.
  518. Astbury NM, Piernas C, Hartmann-Boyce J, Lapworth S, Aveyard P, Jebb SA. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Vol. 20, Obesity Reviews. 2019.
  519. Avenell A, Robertson C, Skea Z, Jacobsen E, Boyers D, Cooper D, et al. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: The rebalance mixed-methods systematic review and economic evaluation. Health Technology Assessment. 2018;22)68).
  520. Gudzune K. Dietary and Behavioral Approaches in the Management of Obesity. Vol. 45, Gastroenterology Clinics of North America. 2016.
  521. U.S. Food & Drugs. FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR )lorcaserin( from the market. 2020.
  522. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: Recommendation statement. American Family Physician. 2019;99(8).
  523. Wing RR, Tate DF, Gorin AA, Raynor HA, Fava JL. A Self-Regulation Program for Maintenance of Weight Loss. New England Journal of Medicine. 2006;355(15).
  524. Wing RR, Phelan S. Long-term weight loss maintenance. Vol. 82, The American journal of clinical nutrition. 2005.
  525. Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. The Safety of Ingested Caffeine: A Comprehensive Review. Frontiers in Psychiatry. 2017;8.
  526. U.S. Preventive Services Task Force. Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors: Behavioral Counseling: Final Recommendation Statement. 2014.
  527. U.S. Preventive Services Task Force. Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions: Final Recommendation Statement. 2020.
  528. הלשכה המרכזית לסטטיסטיקה. לקט נתונים בנושא עישון, מתוך הסקר החברתי 2017. ירושלים 2018
  529. Global Initiative for Chronic Obstructive Lung Disease. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2021 report (Internet). Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20 WMV.pdf
  530. U.S. Preventive Services Task Force. Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions: Final Recommendation Statement. 2018.
  531. מעקב הריון ובדיקות רפואיות בהריון
  532. תזונה בריאה בהריון
  533. &NA; Committee Opinion No. 548. Obstetrics & Gynecology. 2013 Jan;121(1).
  534. Davenport MH, McCurdy AP, Mottola MF, Skow RJ, Meah VL, Poitras VJ, et al. Impact of prenatal exercise on both prenatal and postnatal anxiety and depressive symptoms: A systematic review and meta-analysis. Vol. 52, British Journal of Sports Medicine. 2018.
  535. U.S. Preventive Services Task Force. Perinatal Depression: Preventive Interventions: Final Recommendation Statement. 2019.
  536. Kroenke K, Spitzer RL, Williams JBW. The patient health questionnaire-2: Validity of a two-item depression screener. Medical Care. 2003;41(11).
  537. U.S. Preventive Services Task Force. Depression in Adults: Screening: Final Recommendation Statement. 2016.
  538. מפחיתים את צריכת המלח ושומרים על הבריאות
  539. WHO. Mapping salt reduction initiatives in the WHO European Region (Internet). 2013 (cited 2022 Apr 2). Available from: https://www.euro.who.int/ data/assets/pdf file/0009/186462/Mapping-salt-reduction- initiatives-in-the-WHO-European-Region.pdf
  540. U.S. Preventive Services Task Force. Hypertension in Adults: Screening: Final Recommendation Statement. 2021.
  541. Glechner A, Keuchel L, Affengruber L, Titscher V, Sommer I, Matyas N, et al. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Vol. 12, Primary Care Diabetes. 2018.
  542. U.S. Preventive Services Task Force. Prediabetes and Type 2 Diabetes: Screening: Final Recommendation Statement. 2021.
  543. Kaiser Permanente. Atherosclerotic Cardiovascular Disease )ASCVD( Primary Prevention Guideline. 2020.
  544. טיפול בדיסליפידמיה בישראל - הנחיה קלינית
  545. Wang J, Huang L, Gao Y, Wang Y, Chen S, Huang J, et al. Physically active individuals have a 23% lower risk of any colorectal neoplasia and a 27% lower risk of advanced colorectal neoplasia than their non-active counterparts: Systematic review and meta-analysis of observational studies. British Journal of Sports Medicine. 2019.
  546. Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Vol. 119, British Journal of Cancer. 2018.
  547. Bloomfield HE, Koeller E, Greer N, MacDonald R, Kane R, Wilt TJ. Effects on health outcomes of a mediterranean diet with no restriction on fat intake: A systematic review and meta-analysis. Vol. 165, Annals of Internal Medicine. 2016.
  548. U.S. Preventive Services Task Force. Colorectal Cancer: Screening: Final Recommendation Statement. 2021.
  549. Wu Y, Zhang D, Kang S. Physical activity and risk of breast cancer: A meta-analysis of prospective studies. Breast Cancer Research and Treatment. 2013;137(3).
  550. Xiao Y, Xia J, Li L, Ke Y, Cheng J, Xie Y, et al. Associations between dietary patterns and the risk of breast cancer: A systematic review and meta-analysis of observational studies. Vol. 21, Breast Cancer Research. 2019.
  551. Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC, et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. American Journal of Public Health. 2013;103(4).
  552. Sauter ER. Breast Cancer Prevention: Current Approaches and Future Directions. European Journal of Breast Health. 2018 May 16;
  553. Merry G, Miglioretti D, Lee C, Johnson E, Smith-Bindman R. Breast Cancer Risks from Medical Imaging Including Computed Tomography )CT( and Nuclear Medicine among Females Enrolled in a Large Integrated Health Care System. LL-HPS-TU3A. RSNA; 2012.
  554. Ersser SJ, Effah A, Dyson J, Kellar I, Thomas S, McNichol E, et al. Effectiveness of interventions to support the early detection of skin cancer through skin self-examination: a systematic review and meta-analysis. Vol. 180, British Journal of Dermatology. 2019.
  555. CDC. What Are the Symptoms of Skin Cancer? (Internet). 2021 (cited 2022 Apr 3). Available from: https://www.cdc.gov/cancer/skin/basic info/symptoms.htm
  556. Harper DM, Demars LR. Primary strategies for HPV infection and cervical cancer prevention. Clinical Obstetrics and Gynecology. 2014;57(2).
  557. Zhao J, Stockwell T, Roemer A, Chikritzhs T. Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis. BMC Cancer. 2016;16(1).
  558. Fabiani R, Minelli L, Bertarelli G, Bacci S. A western dietary pattern increases prostate cancer risk: A systematic review and meta-analysis. Nutrients. 2016;8(10).
  559. Applegate CC, Rowles JL, Ranard KM, Jeon S, Erdman JW. Soy consumption and the risk of prostate cancer: An updated systematic review and meta-analysis. Vol. 10, Nutrients. 2018.
  560. Brookman-May SD, Campi R, Henr^quez JDS, Klatte T, Langenhuijsen JF, Brausi M, et al. Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology )ESOU). Vol. 5, European Urology Focus. 2019.
  561. U.S. Preventive Services Task Force. Prostate Cancer: Screening: Final Recommendation Statement. 2018.
  562. U.S. Preventive ServicesTask Force. Osteoporosis to Prevent Fractures: Screening: Final Recommendation Statement. 2018.
  563. U.S. Preventive Services Task Force. Human Immunodeficiency Virus )HIV( Infection: Screening: Final Recommendation Statement. 2019.
  564. U.S. Preventive Services Task Force. Prevention of Human Immunodeficiency Virus )HIV( Infection: Preexposure Prophylaxis: Final Recommendation Statement. 2019.
  565. When to use the new pneumococcal vaccine. Drug and Therapeutics Bulletin. 1990;28(8).
  566. Klinkman MS, Zazove P, Mehr DR, Ruffin IV MT. A criterion-based review of preventive health care in the elderly: Part 1. Theoretical framework and development of criteria. Vol. 34, Journal of Family Practice. 1992.
  567. Zazove P, Mehr DR, Ruffin IV MT, Klinkman MS, Peggs JF, Davies TC. A criterion-based review of preventive health care in the elderly: Part 2. A geriatric health maintenance program. Vol. 34, Journal of Family Practice. 1992.
  568. Doll R, Peto R, Hall E, Wheatley K, Gray R. Alcohol and coronary heart disease reduction among British doctors: Confounding or causality? Vol. 18, European Heart Journal. 1997.
  569. Dowse GK, Gareeboo H, Alberti KGMM, Zimmet P, Tuomilehto J, Purran A, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. BMJ. 1995;311)7015).
  570. יודפת י. היפרליפידמיה: מה חדש ואיך נטפל. כתב העת הישראלי לרפואת המשפחה 48:4-11;1998
  571. יודפת י. מניעה בזיקנה — סקירה ראשית. כתב העת הישראלי לרפואת משפחה .26:4-10;1996
  572. Patterson C, Feightner J. Promoting the health of senior citizens. Vol. 157, CMAJ. 1997.
  573. Clarfield AM, Bass MJ, Cohen C, Feightner JW, Gauthier S, Patterson C, et al. Assessing dementia: The Canadian consensus. Vol. 144, CMAJ. 1991.
  574. Goldberg TH, Chavin SI. Preventive medicine and screening in older adults. Vol. 45, Journal of the American Geriatrics Society. 1997.
  575. Feightner JW, Gass DA, Bass MJ. An Approach to Assessing Dementia: Investigations suitable for use in the family physician's office. Canadian family physician Medecin de famille canadien. 1992;38.
  576. Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension: Final Results of the Systolic Hypertension in the Elderly Program )SHEP). JAMA: The Journal of the American Medical Association. 1991;265)24).
  577. Roccella EJ. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Vol. 157, Archives of Internal Medicine. 1997.
  578. Lever AF, Ramsay LE. Treatment of hypertension in the elderly. Vol. 13, Journal of Hypertension. 1995.
  579. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. British Medical Journal. 1998;317)7158).
  580. US Preventive Services Task Force. Guide to Clinical Preventive Services, ed. 3. 2002.
  581. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed Tomographic Virtual Colonoscopy to Screen for Colorectal Neoplasia in Asymptomatic Adults. New England Journal of Medicine. 2003 Dec 4;349(23).
  582. Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events )CARE( trial. J Am Coll Cardiol. 1998 Jul;32(1).
  583. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 1999;15(6).
  584. American College of Sports Medicine Position Stand. Exercise and physical activity for older adults. Vol. 30, Medicine and science in sports and exercise. 1998.
  585. Tinetti ME. Preventing Falls in Elderly Persons. New England Journal of Medicine. 2003;348(1).
  586. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. J Am Med Assoc. 2002;288(18).
  587. Heflin MT, Cohen HJ. Cancer Screening in the Elderly. Hospital Practice. 2001 Mar 15;36(3).
  588. גלינסקי ד. מבחנים לאיתור זקנים בעלי סיכון גבוה לנפילות בקהילה ופרוטוקולים נלווים. הרפואה -189:)3(138;2000
  589. הלשכה המרכזית לסטטיסטיקה. טבלה 3.24 תוחלת חיים לפי מין, דת וקבוצת אוכלוסייה 2010.
  590. Wu G, Keyes L, Callas P, Ren X, Bookchin B. Comparison of Telecommunication, Community, and Home-Based Tai Chi Exercise Programs on Compliance and Effectiveness in Elders at Risk for Falls. Archives of Physical Medicine and Rehabilitation. 2010;91(6).
  591. Lin JS, O'Connor E, Whitlock EP, Beil TL. Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: A systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2010;153(11).
  592. משרד הבריאות. פירמידת המזון
  593. Lichtenstein AH, Rasmussen H, Yu WW, Epstein SR, Russell RM. Modified mypyramid for older adults. Vol. 138, Journal of Nutrition. 2008.
  594. Savica V, Bellinghieri G, Kopple JD. The the effect of nutrition on blood pressure. Vol. 30, Annual Review of Nutrition. 2010.
  595. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids )Macronutrients). Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids )Macronutrients). 2005.
  596. Oren Y, Shapira Y, Agmon-Levin N, Kivity S, Zafrir Y, Altman A, et al. Vitamin D insufficiency in a sunny environment: A demographic and seasonal analysis. Israel Medical Association Journal. 2010;12(12).
  597. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. Journal of Clinical Investigation. 1985;76(4).
  598. National Institutes of Health. Vitamin B12.
  599. Centers for Disease Control and Prevention. Water: Meeting Your Daily Fluid Needs.
  600. Zizza CA, Ellison KJ, Wernette CM. Total water intakes of community-living middle-old and oldest-old adults. Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2009;64(4).
  601. Schols JMGA, de Groot CPGM, van der Cammen TJM, Olde Rikkert MGM. Preventing and treating dehydration in the elderly during periods of illness and warm weather. Journal of Nutrition, Health and Aging. 2009;13(2).
  602. המלצות תזונתיות למניעת מחלות קרדיווסקולריות - נייר עמדה
  603. The Nationl Academics os Sciences Engineering Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. 2005.
  604. Behavioral counseling in primary care to promote a healthy diet. American Journal of Preventive Medicine. 2003 Jan;24(1).
  605. McTigue KM, Hess R, Ziouras J. Obesity in older adults: A systematic review of the evidence for diagnosis and treatment. Vol. 14, Obesity. 2006.
  606. Holt HL, Katz JN, Reichmann WM, Gerlovin H, Wright EA, Hunter DJ, et al. Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60-64 year-old US adults. Osteoarthritis and Cartilage. 2011;19(1).
  607. Witham MD, Avenell A. Interventions to achieve long-term weight loss in obese older people. A systematic review and meta-analysis. Vol. 39, Age and Ageing. 2010.
  608. Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight Loss, Exercise, or Both and Physical Function in Obese Older Adults. New England Journal of Medicine. 2011;364(13).
  609. שמש ע, רסולי א. בריאות הקשישים בקהילה מתוך נתוני סקר בני 60 ומעלה, 1997-1998, הלשכה המרכזית .2003 ;לסטטיסטיקה. משרד הבריאות
  610. Culberson JW. Alcohol use in the elderly: beyond the CAGE. Part 2: Screening instruments and treatment strategies. Geriatrics. 2006;61(11).
  611. Screening and Behavioral Counseling Interventions in Primary Care To Reduce Alcohol Misuse: Recommendation Statement. Annals of Internal Medicine. 2004 Apr 6;140(7).
  612. Neumark YD, Lopez-Quintero C, Grinshpoon A, Levinson D. Alcohol drinking patterns and prevalence of alcohol-abuse and dependence in the Israel national health survey. Vol. 44, Israel Journal of Psychiatry and Related Sciences. 2007.
  613. Lin J, Eder M, Weinmann S, Zuber S, Beil T, Plaut D, et al. Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 U.S. Preventive Services Task Force Recommendation. Rockville MD; 2011.
  614. Brawley EC. Enriching lighting design. NeuroRehabilitation. 2009;25(3).
  615. Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP, Vitiello M v., et al. Circadian Rhythm Sleep Disorders: Part I, Basic Principles, Shift Work and Jet Lag Disorders. Sleep. 2007 Nov;30(11).
  616. Recommended Adult Immunization Schedule — United States, 2011. Morbidity and Mortality Weekly Report. 2011 Feb 4;60(4).
  617. U.S. Preventive Services Task Force. Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication. 2009.
  618. Collins R, Peto R, Hennekens C, Doll R, Bubes V, Buring J, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. The Lancet. 2009;373)9678).
  619. U.S. Preventive Services Task Force. Colorectal Cancer: Screening: Final Recommendation Statement. 2008.
  620. Tinetti ME, Kumar C. The Patient Who Falls. JAMA. 2010 Jan 20;303(3).
  621. Screening for Depression in Adults: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2009 Dec 1;151(11).
  622. Keilman LJ. Urinary incontinence: Basic evaluation and management in the primary care office. Vol. 32, Primary Care - Clinics in Office Practice. 2005.
  623. Pham C, Dickman R. Minimizing Adverse Drug Events in Older Patients. American Family Physician. 2007;76)12(:1838-44.
  624. Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008 Mar 15;336)7644).
  625. Screening for Impaired Visual Acuity in Older Adults: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2009 Jul 7;151(1).
  626. Chou R, Dana T, Bougatsos C, Fleming C, Beil T. Screening adults aged 50 years or older for hearing loss: A review of the evidence for the U.S. preventive services task force. Annals of Internal Medicine. 2011;154(5).
  627. Mosqueda L, Dong X. Elder Abuse and Self-neglect. JAMA. 2011 Aug 3;306(5).
  628. מניעה וגילוי מוקדם של מחלות ממאירות - חוזר מנכ"ל - Malignancy prevention and early detection
  629. הלשכה המרכזית לסטטיסטיקה. תוחלת חיים לפי מין, דת וקבוצת אוכלוסייה
  630. Bauman A, Merom D, Bull FC, Buchner DM, Fiatarone Singh MA. Updating the Evidence for Physical Activity: Summative Reviews of the Epidemiological Evidence, Prevalence, and Interventions to Promote "active Aging." Vol. 56, Gerontologist. 2016.
  631. Alves AJ, Viana JL, Cavalcante SL, Oliveira NL, Duarte JA, Mota J, et al. Physical activity in primary and secondary prevention of cardiovascular disease: Overview updated. World Journal of Cardiology. 2016;8(10).
  632. Taylor D. Physical activity is medicine for older adults. Vol. 90, Postgraduate Medical Journal. 2014.
  633. Gine-Garriga M, Roque-F^guls M, Coll-Planas L, Sitja-Rabert M, Salva A. Physical exercise interventions for improving performance-based measures of physical function in community-dwelling, frail older adults: A systematic review and meta-analysis. Vol. 95, Archives of Physical Medicine and Rehabilitation. 2014.
  634. de Labra C, Guimaraes-Pinheiro C, Maseda A, Lorenzo T, Millan-Calenti JC. Effects of physical exercise interventions in frail older adults: A systematic review of randomized controlled trials Physical functioning, physical health and activity. Vol. 15, BMC Geriatrics. 2015.
  635. Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement. Vol. 324, JAMA - Journal of the American Medical Association. 2020.
  636. Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. British Journal of Sports Medicine. 2020 Dec;54)24).
  637. U.S. Department of Health & Human Services. Exercise and Physical Activity.
  638. Muscaritoli M, Krznaric Z, Singer P, Barazzoni R, Cederholm T, Golay A, et al. Effectiveness and efficacy of nutritional therapy: A systematic review following Cochrane methodology. Vol. 36, Clinical Nutrition. 2017.
  639. NIH. Vitamin D (Internet). 2021 (cited 2022 Apr 3). Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
  640. National Institutes of Health: Fact Sheet for Health Professionals. Calcium. 2021.
  641. Quagliani D, Felt-Gunderson P. Closing America's Fiber Intake Gap: Communication Strategies From a Food and Fiber Summit. Vol. 11, American Journal of Lifestyle Medicine. 2017.
  642. National Institutes of Health. Vitamin B12: Fact Sheet for Health Professionals. 2021.
  643. European Food Safety Authority )EFSA). Scientific Opinion on Dietary Reference Values for water1 EFSA Panel on Dietetic Products, Nutrition, and Allergies )NDA). EFSA Journal. 2010;8)3(:1-48.
  644. Masot O, Miranda J, Santamaria AL, Pueyo EP, Pascual A, Botigue T Fluid intake recommendation considering the physiological adaptations of adults over 65 years: A critical review. Vol. 12, Nutrients. 2020.
  645. Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. Vol. 325, JAMA - Journal of the American Medical Association. 2021.
  646. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Garc^a FAR, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults. JAMA. 2016 Nov 15;316(19).
  647. Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Screening for Abdominal Aortic Aneurysm. JAMA. 2019 Dec 10;322(22).
  648. Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Colorectal Cancer. JAMA. 2021 May 18;325(19).
  649. U.S. Preventive Services Task Force. Screening for Breast Cancer: An Update for This Topic is In Progress. 2021.
  650. Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, et al. Screening for Lung Cancer. JAMA. 2021 Mar 9;325(10).
  651. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for osteoporosis to prevent fractures us preventive services task force recommendation statement. JAMA - Journal of the American Medical Association. 2018;319)24).
  652. Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Interventions to Prevent Falls in Community-Dwelling Older Adults. JAMA. 2018 Apr 24;319(16).
  653. Siu AL, Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW, Ebell M, et al. Screening for depression in adults: US preventive services task force recommendation statement. JAMA - Journal of the American Medical Association. 2016;315(4).
  654. Halli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: Evaluating risks and deprescribing. American Family Physician. 2019;100(1).
  655. Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Vol. 99, American Family Physician. 2019.
  656. 2019 Aug .משרד הבריאות. דו"ח סקר דמנציה בבני 45 ומעלה לשנת 2016
  657. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Vol. 396, The Lancet. 2020.
  658. Table 1PAF for 12 dementia risk factors. The Lancet.
  659. World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. Who. 2019.
  660. Global Council on Brain Health. The Brain-Heart Connection: GCBH Recommendations to Manage Cardiovascular Risks to Brain Health. Washington, DC; 2020 Feb.
  661. Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Screening for Cognitive Impairment in Older Adults. JAMA. 2020 Feb 25;323(8).
  662. Falk N, Cole A, Meredith TJ. Evaluation of Suspected Dementia. Vol. 97, American family physician. 2018.
  663. O'Reilly N, Nelson HD, Conry JM, Frost J, Gregory KD, Kendig SM, et al. Screening for Urinary Incontinence in Women: A Recommendation From the Women's Preventive Services Initiative. Annals of Internal Medicine. 2018 Sep 4;169(5).
  664. Molnar F, Frank C, Chun S, Lee EK. Insomnia in older adults: Approaching a clinical challenge systematically. Canadian family physician Medecin de famille canadien. 2021;67(1).
  665. Screening for impaired visual acuity in older adults: Recommendation statement. Vol. 93, American Family Physician. 2016.
  666. Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Hearing Loss in Older Adults. JAMA. 2021 Mar 23;325(12).
  667. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults. JAMA. 2018 Oct 23;320(16).
  668. Grossman DC, Curry SJ, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults. JAMA. 2018 Apr 17;319(15).
  669. Kossioni AE, Hajto-Bryk J, Janssens B, Maggi S, Marchini L, McKenna G, et al. Practical Guidelines for Physicians in Promoting Oral Health in Frail Older Adults. J Am Med Dir Assoc. 2018;19(12).
  670. Solberg LI. Guideline implementation: what the literature doesn't tell us. Jt Comm J Qual Improv. 2000;26(9).
  671. Weingarten S. Using practice guideline compendiums to provide better preventive care. Vol. 130, Annals of Internal Medicine. 1999.
  672. Solberg LI, Kottke TE, Brekke ML. Will primary care clinics organize themselves to improve the delivery of preventive services? A randomized controlled trial. Preventive Medicine. 1998;27(4).
  673. Gottlieb NH, Huang PP, Blozis SA, Guo JL, Murphy Smith M. The impact of Put Prevention into Practice on selected clinical preventive services in five Texas sites. American Journal of Preventive Medicine. 2001;21(1).
  674. Goodwin MA, Zyzanski SJ, Zronek S, Ruhe M, Weyer SM, Konrad N, et al. A clinical trial of tailored office systems for preventive service delivery: The Study to Enhance Prevention by Understanding Practice )STEP-UP). American Journal of Preventive Medicine. 2001;21(1).
  675. Hash RB, Munna RK, Vogel RL, Bason JJ. Does physician weight affect perception of health advice? Preventive Medicine. 2003;36(1).
  676. Pal B. The doctor will text you now: Is there a role for the mobile telephone in health care? BMJ. 2003;326)7389).
  677. Cornuz J, Ghali WA, di Carlantonio D, Pecoud A, Paccaud F. Physicians attitudes towards prevention: Importance of intervention-specific barriers and physicians health habits. Family Practice. 2000;17(6).
  678. תדריך להערכת גדילה ומצב תזונתי מהלידה עד גיל 6 שנים - חוזר משרד הבריאות
  679. הלשכה המרכזית לסטטיסטיקה. סקר בריאות, 2009, ממצאים כלליים
  680. טיפולי שיניים לילדים ולנוער
  681. Marcenes W, Kassebaum NJ, Bernabe E, Flaxman A, Naghavi M, Lopez A, et al. Global burden of oral conditions in 1990-2010: A systematic analysis. Journal of Dental Research. 2013;92(7).
  682. משרד הבריאות. הנחיות לשימוש בתכשירי פלואוריד. הנחיות בריאות השן מס' 2.3, 2021
  683. וולפין ג. איך כדאי לצחצח שיניים ולשמור על בריאות טובה של הפה? ההסתדרות לרפואת שיניים בישראל 2016 .
  684. טוביאס ג, מן י, סגן כהן ה. המלחמה נגד המלחמה נגד הפלרת מים (נכון לימים אלו). עדכן רפואת שיניים
  685. ישראל. חוק ביטוח בריאות ממלכתי, התשנ"ד-1994
  686. Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2000. 2001;25(1).
  687. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians. 2010;60(5).
  688. Zini A, Czerninski R, Vered Y, Livny A, Sgan-Cohen HD. Trends of oral and pharyngeal cancer in Israel, by gender, age, ethnic group, and country of origin: 1970-2006. Community Dentistry and Oral Epidemiology. 2009;37(6).
  689. Weiss J, Gardner HG, Baum CR, Dowd MD, Durbin DR, Ebel BE, et al. Technical report - Prevention of drowning. Vol. 126, Pediatrics. 2010.
  690. Gardner HG, Smith GA, Baum CR, Dowd MD, Durbin DR, Sege RD, et al. Office-based counseling for unintentional injury prevention. Pediatrics. 2007;119(1).
  691. Altkorn R, Chen X, Milkovich S, Stool D, Rider G, Bailey CM, et al. Fatal and non-fatal food injuries among children )aged 0-14 years). International Journal of Pediatric Otorhinolaryngology. 2008;72(7).
  692. Moon RY, Darnall RA, Feldman-Winter L, Goodstein MH, Hauck FR. SIDS and other sleep-related infant deaths: Evidence base for 2016 updated recommendations for a safe infant sleeping environment. Pediatrics. 2016;138(5).
  693. מכון התקנים. מידע לצרכן בנושא ריהוט לתינוק
  694. U.S. Consumer Product Safety Commission. Product Instability or Tip-Over Injuries and Fatalities Associated with Televisions, Furniture, and Appliances: 2019 Report (Internet). 2019 (cited 2022 Apr 9). Available from: https://www.cpsc.gov/s3fs-public/2019 Tip Over Report 0.pdf
  695. European Child Safety Alliance. Child Safety Good Practice Guide: Good investments in unintentional child injury prevention and safety promotion. 2006.
  696. Webne SL, Kaplan BJ. Preventing tap water scalds: Do consumers change their preset thermostats? American Journal of Public Health. 1993;83(10).
  697. DiGuiseppi C, Roberts I, Li L. Smoke alarm ownership and house fire death rates in children. Journal of Epidemiology and Community Health. 1998;52(11).
  698. המלצות שימוש ורכישת תנורי חימום
  699. Henary B, Sherwood CP, Crandall JR, Kent RW, Vaca FE, Arbogast KB, et al. Car safety seats for children: rear facing for best protection. Injury Prevention. 2007 Dec 3;13(6).
  700. Durbin DR, Gardner HG, Baum CR, Dowd MD, Ebel BE, Ewald MB, et al. Policy statement - Child passenger safety. Vol. 127, Pediatrics. 2011.
  701. Kalian MJ, Durbin DR, Arbogast KB. Seating patterns and corresponding risk of injury among 0 to 3-year- old children in child safety seats. Pediatrics. 2008;121(5).
  702. Durbin DR, Chen I, Smith R, Elliott MR, Winston FK. Effects of seating position and appropriate restraint use on the risk of injury to children in motor vehicle crashes. Pediatrics. 2005;115(3).
  703. מניעת השארת ילדים ברכב
  704. MacK KA, Dellinger A, West BA. Adult opinions about the age at which children can be left home alone, bathe alone, or bike alone: Second Injury Control and Risk Survey )ICARIS-2). Journal of Safety Research. 2012;43(3).
  705. Wynn PM, Zou K, Young B, Majsak-Newman G, Hawkins A, Kay B, et al. Prevention of childhood poisoning in the home: overview of systematic reviews and a systematic review of primary studies. Vol. 23, International Journal of Injury Control and Safety Promotion. 2016.
  706. Turner C, Spinks A, McClure RJ, Nixon J. Community-based interventions for the prevention of burns and scalds in children. Cochrane Database of Systematic Reviews. 2004;
  707. World Health Organization. Global report on drowning: preventing a leading killer. 2014 Nov.
  708. World Report on Child Injury Prevention. 2008.
  709. Bull MJ, Agran P, Gardener HG, Laraque D, Pollack SH, Smith GA, et al. Falls from heights: Windows, roofs, and balconies. Pediatrics. 2001;107(5).
  710. Consumer Product Safety Commission. Product instability or Tip-over injuries and fatalities associated with televisions, furniture, and appliances. 2016.
  711. Gardner HG, Baum CCR, Dowd MD, Durbin DR, Lichenstein R, Quinlan KP, et al. Policy statement - Prevention of choking among children. Pediatrics. 2010;125(3).
  712. Thompson DC, Rivara F, Thompson R. Helmets for preventing head and facial injuries in bicyclists. Cochrane Database of Systematic Reviews. 1999 Oct 25;
  713. Drago DA, Winston FK, Baker SP. Clothing drawstring entrapment in playground slides and school buses: Contributing factors and potential interventions. Archives of Pediatrics and Adolescent Medicine. 1997;151(1).
  714. Consumer Product Safety Commission. Drawstrings in Children's Upper Outerwear (Internet). (cited 2022 Apr 9). Available from: https://www.cpsc.gov/Business--Manufacturing/Business-Education/Business- Guidance/Drawstrings-in-Childrens-Upper-Outerwear
  715. Brussoni M, Olsen LL, Pike I, Sleet DA. Risky play and children's safety: Balancing priorities for optimal child development. Vol. 9, International Journal of Environmental Research and Public Health. 2012.
  716. תקנות התעבורה 83א
  717. חוק העונשין, התשל"ז-1977. סעיף 361
  718. Anderst J, Moffatt M. Adequate supervision for children and adolescents. Pediatr Ann. 2014;43(11).
  719. Thompson DC, Rivara FP, Thompson R. Helmets for preventing head and facial injuries in bicyclists. Nurs Times. 2001;97)43).
  720. Smith GA, Baum CR, Dowd MD, Durbin DR, Quinlan KP, Sege RD, et al. Policy statement - Pedestrian safety. Vol. 124, Pediatrics. 2009.
  721. המלצות רשות הטבע והגנים
  722. Williams AF. Young driver risk factors: Successful and unsuccessful approaches for dealing with them and an agenda for the future. Vol. 12, Injury Prevention. 2006.
  723. הרשות הלאומית לבטיחות בדרכים. רישיון נהיגה מדורג
  724. ישראל. תקנות התעבורה, התשכ"א-1961. סעיפים 136-126
  725. תדריך חיסונים
  726. לוח חיסוני השגרה בגיל הילדות ובבתי ספר - Vaccination schedule for children and school aged patients - 2018
  727. לוח חיסון מבוגרים המומלץ על ידי משרד הבריאות - 2014 - Vaccines recommended for adults by the israeli ministry of health
  728. חיסון נגד דלקת כבד
  729. חיסון נגד שיתוק ילדים
  730. תדריך חיסונים - אסכרה-פלצת אסלולרי - Diphtheria-Tetanus acellular pertussis
  731. תדריך חיסונים - המופילוס אינפלואנזה - Haemophilus influenzae - b
  732. תדריך חיסונים - חיסון נגד זיהומים פנוימוקוקיים - Pneumococcal vaccine
  733. תדריך חיסונים - חיסון נגד זיהום הנגרם על ידי נגיף רוטה - Oral rotavirus vaccine
  734. תדריך חיסונים - חצבת-חזרת-אדמת - Measles-mumps-rubella
  735. תרכיבים נגד אבעבועות רוח - Varicella vaccines
  736. חיסון נגד דלקת כבד
  737. תדריך חיסונים - חיסון נגד זיהומים הנגרמים על ידי נגיף הפפילומה באדם - Human papillomavirus vaccines
  738. תדריך חיסונים - חיסון נגד שפעת - Influenza Vaccines
  739. Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, D^ez-Domingo J, et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. New England Journal of Medicine. 2016;375(11).
  740. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. New England Journal of Medicine. 2015;372(22).
  741. Centers for Disease Control and Prevention. Meningococcal Disease (Internet). (cited 2021 Oct 26). Available from: https://www.cdc.gov/meningococcal/index.html
  742. סיכום ישיבת הועדה המיעצת למחלות זיהומיות ולחיסונים על השימוש בחיסון בקסרו נגד מנינגוקוק B (2014)
  743. Ladhani SN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, et al. Vaccination of Infants with Meningococcal Group B Vaccine )4CMenB( in England. New England Journal of Medicine. 2020;382(4).
  744. תדריך חיסונים - דרכי מניעה ופיקוח על מחלה מנינגוקוקית - Prevention and control of meningococcal disease
  745. ההמלצות התזונתיות החדשות - משרד הבריאות
  746. Burlingame B, Dernini S, Nutrition and Consumer Protection Division, editors. Sustainable Diets and Biodiversity. In: Biodiversity and Sustainable Diets United against Hunger. Rome; 2010.
  747. Carlsson-Kanyama A, Gonzalez AD. Potential contributions of food consumption patterns to climate change. In: American Journal of Clinical Nutrition. 2009.
  748. Horrigan L, Lawrence RS, Walker P. How sustainable agriculture can address the environmental and human health harms of industrial agriculture. Vol. 110, Environmental Health Perspectives. 2002.
  749. Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A, Dernini S, et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutrition. 2011;14)12A).
  750. תזונה בריאה בהיריון
  751. האכלת התינוק בשנה הראשונה
  752. הסימון הירוק - סימון חיובי על מוצרי מזון
  753. פעילות גופנית במסגרת מניעה ראשונית ושניונית של מחלות לב וכלי דם
  754. מרשם אישי לאימון גופני ולבריאות
  755. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/ PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. Circulation. 2014 Nov 4;130(19).
  756. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021 Jan;44)Supplement 1).
  757. Pescatello LS, MacDonald H v., Lamberti L, Johnson BT. Exercise for Hypertension: A Prescription Update Integrating Existing Recommendations with Emerging Research. Vol. 17, Current Hypertension Reports. 2015.
  758. Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: Systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. Vol. 354, BMJ )Online). 2016.
  759. Khan KM, Thompson AM, Blair SN, Sallis JF, Powell KE, Bull FC, et al. Sport and exercise as contributors to the health of nations. Vol. 380, The Lancet. 2012.
  760. American Diabetes Association. Lifestyle Management: Standards of Medical Care in Diabetes.
  761. Pandey A, Salahuddin U, Garg S, Ayers C, Kulinski J, Anand V, et al. Continuous dose-response association between sedentary time and risk for cardiovascular disease a meta-analysis. JAMA Cardiology. 2016;1(5).
  762. Schmid D, Leitzmann MF. Television viewing and time spent sedentary in relation to cancer risk: A metaanalysis. Vol. 106, Journal of the National Cancer Institute. 2014.
  763. Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. The Lancet. 2016;388)10051).
  764. Arem H, Moore SC, Patel A, Hartge P, Berrington De Gonzalez A, Visvanathan K, et al. Leisure time physical activity and mortality: A detailed pooled analysis of the dose-response relationship. JAMA Internal Medicine. 2015;175(6).
  765. Patel A v., Hildebrand JS, Leach CR, Campbell PT, Doyle C, Shuval K, et al. Walking in Relation to Mortality in a Large Prospective Cohort of Older U.S. Adults. American Journal of Preventive Medicine. 2018;54(1).
  766. פעילות גופנית וספורט בילדים ובבני נוער - נייר עמדה
  767. American College of Sport Medicine. Health Care Providers' Action Guide (Internet). (cited 2021 Oct 26). Available from: https://www.exerciseismedicine.org/assets/page documents/EIM%20Health%20Care%20Providers%20Action%20Guide.pdf
  768. World Health Organization. Physical Activity (Internet). 2020 (cited 2021 Oct 26). Available from: https://www.who.int/news-room/fact-sheets/detail/physical-activity
  769. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations. J Am Coll Cardiol. 2015;66)21).
  770. Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1).
  771. Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Vol. 5, The Lancet Diabetes and Endocrinology. 2017.
  772. המדריך לטיפול בסוכרת
  773. Chin SH, Kahathuduwa CN, Binks M. Physical activity and obesity: what we know and what we need to know*. Obesity Reviews. 2016;17(12).
  774. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of cardiology/American Heart Association task force on practice guidelines and the obesity society. Vol. 129, Circulation. 2014.
  775. יתר לחץ דם - הנחיה קלינית
  776. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/ AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19).
  777. Rezende LFM de, Sa TH de, Markozannes G, Rey-Lopez JP, Lee IM, Tsilidis KK, et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br J Sports Med. 2018;52(13).
  778. Powell KE, Paluch AE, Blair SN. Physical activity for health: What kind? how much? how intense? on top of what? Annual Review of Public Health. 2011;32.
  779. Cormie P, Zopf EM, Zhang X, Schmitz KH. The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiologic Reviews. 2017;39(1).
  780. Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Internal Medicine. 2016;176(6).
  781. Li T, Wei S, Shi Y, Pang S, Qin Q, Yin J, et al. The dose-response effect of physical activity on cancer mortality: Findings from 71 prospective cohort studies. Vol. 50, British Journal of Sports Medicine. 2016.
  782. Jensen MT, Holtermann A, Bay H, Gyntelberg F. Cardiorespiratory fitness and death from cancer: A 42- year follow-up from the Copenhagen Male Study. British Journal of Sports Medicine. 2017;51(18).
  783. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/ PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60)24).
  784. Riebe D, Franklin BA, Thompson PD, Garber CE, Whitfield GP, Magal M, et al. Updating ACSM's recommendations for exercise preparticipation health screening. Medicine and Science in Sports and Exercise. 2015;47(11).
  785. ישראל. חוק מכוני כושר (רישוי ופיקוח) (תיקון מס' 2), התשע"ה-2015
  786. Erratum: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines )Circulation )2019( 140 )e596-e646( DOI: 10.1161/CIR.0000000000000678). Circulation. 2020.
  787. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Vol. 41, European Heart Journal. 2020.
  788. American College of Cardiology. ASCVD Risk Estimator Plus (Internet). (cited 2021 Oct 27). Available from: https://tools.acc.org/ASCVD-Risk-Estimator-Plus/#!/calculate/estimate/
  789. European Society of Cardiology. SCORE Risk Charts (Internet). (cited 2021 Oct 27). Available from: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts
  790. Catapano AL, Graham I, de Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal. 2016 Oct 14;37(39).
  791. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/ AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73)24).
  792. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease. Endocrine Practice. 2017 Apr;23.
  793. World Health Organization. Body mass index - BMI (Internet). (cited 2021 Oct 27). Available from: https:// www.euro.who. int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index- bmj_
  794. di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet. 2016 Aug;388)10046).
  795. Padwal R, Leslie WD, Lix LM, Majumdar SR. Relationship among body fat percentage, body mass index, and all-cause mortality: A Cohort Study. Annals of Internal Medicine. 2016;164(8).
  796. HeartSCORE. HeartSCORE calculator (Internet). (cited 2021 Oct 27). Available from: https://www.heartscore.org/en GB/
  797. Tschiderer L, Seekircher L, Kunutsor SK, Peters SAE, O'Keeffe LM, Willeit P. Breastfeeding Is Associated With a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta-Analysis Involving Data From 8 Studies and 1 192 700 Parous Women. J Am Heart Assoc. 2022 Jan 18;11(2).
  798. ניהול מעקב אישה הרה בהיריון בסיכון נמוך
  799. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Garcia FAR, et al. Folic acid supplementation for the prevention of neural tube defects US preventive services task force recommendation statement. Vol. 317, JAMA - Journal of the American Medical Association. 2017.
  800. Sacks DA, Coustan DR, Hadden DR, Hod M, Maresh M, Oats JJN, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care. 2012;35(3).
  801. U.S. Preventive Services Task Force. Final Recommendation: Statement Asymptomatic Bacteriuria in Adults: Screening (Internet). 2019 (cited 2022 Apr 10). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-in- adults-screening
  802. בדיקת GBS) Group B Streptococcus) בנשים הרות - חוזר משרד הבריאות - Screening for Group B Streptococcus (GBS) in pregnancy
  803. Lazarin GA, Haque IS, Nazareth S, Iori K, Patterson AS, Jacobson JL, et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: Results from an ethnically diverse clinical sample of 23,453 individuals. Genetics in Medicine. 2013;15(3).
  804. Lazarin GA, Hawthorne F, Collins NS, Platt EA, Evans EA, Haque IS. Systematic classification of disease severity for evaluation of expanded carrier screening panels. PLoS ONE. 2014;9(12).
  805. Lazarin GA, Haque IS. Expanded carrier screening: A review of early implementation and literature. Vol. 40, Seminars in Perinatology. 2016.
  806. Edwards JG, Feldman G, Goldberg J, Gregg AR, Norton ME, Rose NC, et al. Expanded carrier screening in reproductive medicine-points to consider. Vol. 125, Obstetrics and Gynecology. 2015.
  807. Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genetics in Medicine. 2013;15(6).
  808. Nazareth SB, Lazarin GA, Goldberg JD. Changing trends in carrier screening for genetic disease in the United States. Vol. 35, Prenatal Diagnosis. 2015.
  809. Martin J, Asan, Yi Y, Alberola T, Rodr^guez-Iglesias B, Jimenez-Almazan J, et al. Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology. Fertility and Sterility. 2015;104(5).
  810. בדיקות סקר באוכלוסייה לשם גילוי זוגות בסיכון ללידת ילדים עם מחלות תורשתיות חמורות - חוזר משרד הבריאות - Prenatal genetic carrier screening for serious genetic diseases
  811. משרד הבריאות. בדיקות סקר לגילוי נשאות למחלות גנטיות בישראל - סיכום של השנה הראשונה של התוכנית
  812. בדיקות גנטיות - "סקר גנטי"
  813. Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncology. 2015;1(6).
  814. Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, et al. DNA Sequencing versus Standard Prenatal Aneuploidy Screening. New England Journal of Medicine. 2014;370(9).
  815. Committee Opinion No. 545. Obstetrics & Gynecology. 2012 Dec;120(6).
  816. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/ noninvasive prenatal diagnosis: The position of the National Society of Genetic Counselors. Journal of Genetic Counseling. 2013;22(3).
  817. Eunethta. Screening of Fetal Trisomies 21, 18 And 13 by Noninvasive Prenatal Testing Project ID: Otca03 (Internet). Joint Action 3 WP4. 2018 (cited 2021 Oct 27). Available from: https://www.eunethta.eu/wp-content/uploads/2018/03/OTCA03 and-13-by-noninvasive-prenatal-testing V1.5.pdf
  818. Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Vol. 50, Ultrasound in Obstetrics and Gynecology. 2017.
  819. Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine. 2016;18(10).
  820. International Society for Prenatal Diagnosis. Position Statement from the Aneuploidy Screening Committee on Behalf of the Board of the International Society for Prenatal Diagnosis, April 2013 (Internet). 2013 (cited 2021 Oct 27). Available from: https://www.ispdhome.org/docs/ISPD/Society%20Statements/PS Aneuploidy 2013April.pdf
  821. Norem CT, Schoen EJ, Walton DL, Krieger RC, O'Keefe J, To TT, et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstetrics and Gynecology. 2005;106(4).
  822. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, et al. Cell-free DNA Analysis for Noninvasive Examination of Trisomy. New England Journal of Medicine. 2015;372(17).
  823. Roman AS, Gupta S, Fox NS, Saltzman D, Klauser CK, Rebarber A. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds? Fetal Diagnosis and Therapy. 2015;37(3).
  824. Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound in Obstetrics and Gynecology. 2018;51(6).
  825. Yaron Y, Jani J, Schmid M, Oepkes D. Current status of testing for microdeletion syndromes and rare autosomal trisomies using cell-free DNA technology. Vol. 126, Obstetrics and Gynecology. 2015.
  826. ייעוץ גנטי לשם אבחון מחלות או מומים בעובר לקראת הריון או במהלכו
  827. בדיקות סקר לתסמונת דאון - חוזר משרד הבריאות
  828. בדיקת דנ”א עוברי בדם האם לאיתור הפרעות מספריות בכרומוזומים
  829. Jorenby D. Clinical Efficacy of Bupropion in the Management of Smoking Cessation. Drugs. 2002;62)Supplement 2).
  830. Rigotti NA. Treatment of Tobacco Use and Dependence. New England Journal of Medicine. 2002 Feb 14;346(7).
  831. שטיינברג א, לוגר א, ממן ע, שטיינברג ש. השפעת העישון על מחלות אורתופדיות ותוצאות ניתוחים. הרפואה 2003;142)6(:442-5.
  832. Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. The Lancet. 2002 Oct;360)9339).
  833. דו״ח שר הבריאות על העישון בישראל 2003-2002
  834. Burns D, Garfinkel L, Samet J, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Changes in cigarette-related disease risks and their implication for prevention and control Smoking and Tobacco Control Monograph, No. 8, Publication 974213. 1997.
  835. Zevin S, Benowitz NL. Drug Interactions with Tobacco Smoking. Clinical Pharmacokinetics. 1999;36(6).
  836. Burns DM. Nicotine Addiction. In: Braunwald E, Hauser SL, Fauci AS, editors. Harrison's Principles of Internal Medicine. 15th ed. McGraw Hill; 2001. p. 2574-7.
  837. Schroeder SA. What to Do With a Patient Who Smokes. JAMA. 2005 Jul 27;294(4).
  838. Lancaster T, Stead L. Physician advice for smoking cessation. In: Stead L, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2004.
  839. Stead LF, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tobacco Control. 2007 Dec 1;16)Supplement 1).
  840. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000 Jun 28;283)24).
  841. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. In: Stead L, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2004.
  842. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. In: Hughes JR, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2007.
  843. Cahill K, Stead L, Lancaster T. Nicotine receptor partial agonists for smoking cessation. In: Cahill K, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2007.
  844. Oncken C. Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation. Archives of Internal Medicine. 2006 Aug 14;166(15).
  845. Jorenby DE. Efficacy of Varenicline, an a402 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE> JAMA. 2006 Jul 5;296(1).
  846. Gonzales D. Varenicline, an a402 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</ SUBTITLE> JAMA. 2006 Jul 5;296(1).
  847. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active Smoking and the Risk of Type 2 Diabetes. JAMA. 2007 Dec 12;298(22).
  848. Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. Annals of Internal Medicine. 2009 Apr 21;150(8).
  849. שירותי בריאות כללית. המלצות מקצועיות להתערבות ראשונית לגמילה מעישון לצוות המרפאה 2010
  850. Hu Y, Zong G, Liu G, Wang M, Rosner B, Pan A, et al. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality. New England Journal of Medicine. 2018 Aug 16;379(7).
  851. Inoue-Choi M, Liao LM, Reyes-Guzman C, Hartge P, Caporaso N, Freedman ND. Association of Long-term, Low-Intensity Smoking With All-Cause and Cause-Specific Mortality in the National Institutes of Health-AARP Diet and Health Study. JAMA Internal Medicine. 2017 Jan 1;177(1).
  852. Werner AK, Koumans EH, Chatham-Stephens K, Salvatore PP, Armatas C, Byers P, et al. Hospitalizations and Deaths Associated with EVALI. New England Journal of Medicine. 2020 Apr 23;382(17).
  853. Narimani M, da Silva G. Does 'Dry Hit' vaping of vitamin E acetate contribute to EVALI? Simulating toxic ketene formation during e-cigarette use. PLOS ONE. 2020 Sep 3;15(9).
  854. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. New England Journal of Medicine. 2019 Feb 14;380(7).
  855. Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults. JAMA Pediatrics. 2017 Aug 1;171(8).
  856. Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment. J Am Coll Cardiol. 2018 Dec;72(25).
  857. Windle SB, Filion KB, Mancini JG, Adye-White L, Joseph L, Gore GC, et al. Combination Therapies for Smoking Cessation. American Journal of Preventive Medicine. 2016 Dec;51(6).
  858. van Rossem C, Spigt M, Viechtbauer W, Lucas AEM, van Schayck OCP, Kotz D. Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care. Addiction. 2017 Dec;112(12).
  859. Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: A review of reviews for the U.S. preventive services task force. Vol. 163, Annals of Internal Medicine. 2015.
  860. HEATHERTON TF, KOZLOWSKI LT, FRECKER RC, RICKERT W, ROBINSON J. Measuring the Heaviness of Smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Addiction. 1989 Jul;84(7).
  861. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders )EAGLES(: a double-blind, randomised, placebo-controlled clinical trial. The Lancet. 2016 Jun;387)10037).
  862. Bar-Zeev Y, Lim LL, Bonevski B, Gruppetta M, Gould GS. Nicotine replacement therapy for smoking cessation during pregnancy. Medical Journal of Australia. 2018 Jan 4;208(1).
  863. משרד הבריאות. מגמות בתחלואה ובתמותה מסרטן בישראל 1970-1995
  864. Swensen SJ. Screening for cancer with computed tomography. BMJ. 2003 Apr 26;326)7395).
  865. איגוד לגסטרואנטרולוגיה. עיון וסיכום עמדת האיגוד לגסטרואנטרולוגיה. הרפואה 142:223-6;2003
  866. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ. 2001 Jul 24;165(2).
  867. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003 Dec 4;349(23).
  868. Siu AL, U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016 Feb 16;164(4).
  869. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002 Oct 2;94(19).
  870. Dixon JM. Screening for breast cancer. BMJ. 2006 Mar 4;332)7540).
  871. Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: A randomised controlled trial. The Lancet Oncology. 2015;16(9).
  872. Rennert G. Fecal occult blood screening--trial evidence, practice and beyond. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2003;163.
  873. Jankowski J, Boulton E. Cancer prevention. BMJ. 2005 Sep 17;331)7517).
  874. PDQ Cancer Information Summaries of the National Cancer Institute.
  875. בר חנא מ, קינן-בוקר ל, פישלר י, ליפשיץ א. אומדן הסיכון לחלות במחלה ממארת לאורך לסרטן המרכז הלאומי לבקרת מחלות 2011
  876. קינן-בוקר ל. שכיחות והיארעות מחלות סרטן לשנים 2013-2012
  877. Siegel RL, Jacobs EJ, Newton CC, Feskanich D, Freedman ND, Prentice RL, et al. Deaths Due to Cigarette Smoking for 12 Smoking-Related Cancers in the United States. JAMA Internal Medicine. 2015 Sep 1;175(9).
  878. GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393)10184).
  879. משרד הבריאות. עדכון נתונים לגבי היארעות סרטן ותמותה מסרטן לשנת 2016
  880. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 Nov 17;151(10).
  881. רנרט ג. התוכנית הלאומית לאיתור מוקדם של סרטן השד
  882. Melnikow J, Fenton J, Miglioretti D, et al. Screening for Breast Cancer With Digital Breast Tomosynthesis. Rockville, MD; 2016.
  883. Lin JS, Piper MA, Perdue LA, Rutter CM, Webber EM, O'Connor E, et al. Screening for Colorectal Cancer. JAMA. 2016 Jun 21;315(23).
  884. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Garc^a FAR, et al. Screening for Colorectal Cancer. JAMA. 2016 Jun 21;315(23).
  885. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Ebell M, Epling JW, et al. Screening for Skin Cancer. JAMA. 2016 Jul 26;316(4).
  886. Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-Specific Antigen-Based Screening for Prostate Cancer. JAMA. 2018 May 8;319(18).
  887. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for Cervical Cancer. JAMA. 2018 Aug 21;320(7).
  888. Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Mar 4;160(5).
  889. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2014 Mar 4;160(5).
  890. Green AK, Bach P. Model-Based Eligibility for Lung Cancer Screening: Where Theory Meets Practice. Annals of Internal Medicine. 2018 Feb 6;168(3).
  891. de Koning H, van der Aalst C, ten Haaf K, Oudkerk M. PL02.05 Effects of Volume CT Lung Cancer Screening: Mortality Results of the NELSON Randomised-Controlled Population Based Trial. Journal of Thoracic Oncology. 2018 Oct;13(10).
  892. Bates CK, Carroll N, Potter J. The challenging pelvic examination. J Gen Intern Med. 2011 Jun;26(6).
  893. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health )Larchmt). 2011 Jan;20(1).
  894. Committee Opinion No. 534. Obstetrics & Gynecology. 2012 Aug;120)2, Part 1).
  895. Qaseem A, Humphrey LL, Harris R, Starkey M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Jul 1;161(1).
  896. Tonelli M, Connor Gorber S, Moore A, Thombs BD, Canadian Task Force on Preventive Health Care. Recommendations on routine screening pelvic examination: Canadian Task Force on Preventive Health Care adoption of the American College of Physicians guideline. Canadian family physician Medecin de famille canadien. 2016 Mar;62(3).
  897. Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, et al. Screening for Gynecologic Conditions With Pelvic Examination. JAMA. 2017 Mar 7;317(9).
  898. ACOG Committee Opinion No. 754: The Utility of and Indications for Routine Pelvic Examination. Obstetrics & Gynecology. 2018 Oct;132(4).
  899. Phipps MG, Son S, Zahn C, O'Reilly N, Cantor A, Frost J, et al. Women's Preventive Services Initiative's Well-Woman Chart. Obstetrics & Gynecology. 2019 Sep;134(3).
  900. מניעה וגילוי מוקדם של מחלות ממאירות - חוזר מנכ"ל - Malignancy prevention and early detection
  901. Mateo J, Lord CJ, Serra V, Tutt A, Balmana J, Castroviejo-Bermejo M, et al. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol. 2019;30(9).
  902. Sokolenko AP, Imyanitov EN. Molecular Diagnostics in Clinical Oncology. Frontiers in Molecular Biosciences. 2018 Aug 27;5.
  903. Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proceedings of the National Academy of Sciences. 2014 Sep 30;111(39).
  904. Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, Kedar-Barnes I, et al. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10).
  905. Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, et al. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015 Jan 15;121(2).
  906. הרחבת סל שירותי הבריאות לשנת 2019 - חוזר משרד הבריאות
  907. בדיקות גנטיות - כולל בדיקות ריצוף מתקדמות (NGS)
  908. Kauff ND. Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. Journal of Medical Genetics. 2002 Aug 1;39(8).
  909. van Marcke C, Collard A, Vikkula M, Duhoux FP. Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data. Critical Reviews in Oncology/Hematology. 2018 Dec;132.
  910. Lindor NM, Goldgar DE, Tavtigian S v., Plon SE, Couch FJ. BRCA1/2 Sequence Variants of Uncertain Significance: A Primer for Providers to Assist in Discussions and in Medical Management. The Oncologist. 2013 May 24;18(5).
  911. Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S, et al. A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet. 2014 Sep;86(3).
  912. Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, et al. Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. JNCI: Journal of the National Cancer Institute. 2017 Jan 1;109(1).
  913. Domchek SM. Association of Risk-Reducing Surgery in BRCA1 or BRCA2& Mutation Carriers With Cancer Risk and Mortality. JAMA. 2010 Sep 1;304(9).
  914. Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AIM, Collee M, Meijers-Heijboer HEJ, et al. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2019 Oct;177(3).
  915. King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project )NSABP-P1( Breast Cancer Prevention Trial. JAMA. 2001 Nov 14;286(18).
  916. Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA -Related Cancer. JAMA. 2019 Aug 20;322(7).
  917. התוויות לביצוע בדיקות שד בתהודה מגנטית במסגרת סל השירותים - חוזר משרד הבריאות
  918. National Comrehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast and Ovarian. 2019.
  919. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18;96(4).
  920. Goldberg Y, Barnes-Kedar I, Lerer I, Halpern N, Plesser M, Hubert A, et al. Genetic features of Lynch syndrome in the Israeli population. Clin Genet. 2015 Jun;87(6).
  921. Baris HN, Barnes-Kedar I, Toledano H, Halpern M, Hershkovitz D, Lossos A, et al. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. Pediatr Blood Cancer. 2016 Mar;63(3).
  922. Eng C. Multiple Endocrine Neoplasia Type 2. GeneReviews.
  923. כאבי גב תחתון - הנחיה קלינית - Low back pain - guidelines
  924. Burton AK, Balague F, Cardon G, Eriksen HR, Henrotin Y, Lahad A, et al. Chapter 2 European guidelines for prevention in low back pain. European Spine Journal. 2006 Mar;15)S2).
  925. Burton AK, Balague F, Cardon G, Eriksen HR, Henrotin Y, Lahad A, et al. Chapter 2: European guidelines for prevention in low back pain November 2004. Vol. 15, European Spine Journal. 2006.
  926. Burton AK, Balague F, Cardon G, Eriksen HR, Hanninen O, Harvey E, et al. How to prevent low back pain. Vol. 19, Best Practice and Research: Clinical Rheumatology. 2005.
  927. קווים מנחים למניעת כאבי גב תחתון
  928. Daltroy LH, Iversen MD, Larson MG, Lew R, Wright E, Ryan J, et al. A Controlled Trial of an Educational Program to Prevent Low Back Injuries. New England Journal of Medicine. 1997;337(5).
  929. Reddell CR, Congleton JJ, Dale Huchingson R, Montgomery JF. An evaluation of a weightlifting belt and back injury prevention training class for airline baggage handlers. Applied Ergonomics. 1992;23(5).
  930. Cox JM, Trier KK. Exercise and smoking habits in patients with and without low back and leg pain. Journal of Manipulative and Physiological Therapeutics. 1987;10(5).
  931. Battie MC, Videman T, Gill K, Moneta GB, Nyman R, Kaprio HJ, et al. 1991 volvo award in clinical sciences: Smoking and lumbar intervertebral disc degeneration: An MRI study of identical twins. Spine )Phila Pa 1976). 1991;16(9).
  932. Holm S, Nachemson A. Nutrition of the Intervertebral Disc: Acute Effects of Cigarette Smoking: An experimental animal study. Upsala Journal of Medical Sciences. 1988;93(1).
  933. Gore DR, Passehl R, Sepic S, Dalton A. Scoliosis screening: Results of a community project. Pediatrics. 1981;67(2).
  934. International Civil Aviation Organization. Manual of Civil Aviation Medicine, Doc 8984 AN/895. 2002.
  935. Roach GD, Sargent C. Interventions to Minimize Jet Lag After Westward and Eastward Flight. Frontiers in Physiology. 2019 Jul 31;10.
  936. Hampson NB, Kregenow DA, Mahoney AM, Kirtland SH, Horan KL, Holm JR, et al. Altitude exposures during commercial flight: a reappraisal. Aviat Space Environ Med. 2013 Jan;84(1).
  937. Smith D, Toff W, Joy M, Dowdall N, Johnston R, Clark L, et al. Fitness to fly for passengers with cardiovascular disease. Heart. 2010 Aug 1;96)Suppl 2).
  938. U.S. Department of Transportation Federal Aviation Administration Flight Standards Service. Altitude- Induced Decompression Sickness )DCS). In: Pilot's Handbook of Aeronautical Knowledge (Internet). 2016 (cited 2022 Feb 21). Available from: https://www.faa.gov/regulations_policies/handbooks_manuals/aviation/phak/media/pilot_handbook.pdf
  939. Samuel O, Tal D. Airsickness: Etiology, treatment, and clinical importance—a review. Vol. 180, Military Medicine. 2015.
  940. Takov V, Tadi P. Motion Sickness. 2021.
  941. Brainard A, Gresham C. Prevention and treatment of motion sickness. American Family Physician. 2014;90(1).
  942. Miller KE, Muth ER. Efficacy of Acupressure and Acustimulation Bands for the Prevention of Motion Sickness. Aviation Space and Environmental Medicine. 2004;75)3 SEC. I).
  943. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141)2 SUPPL.).
  944. Centers for Disease Control and Prevention. Blood Clots During Travel.
  945. Marques MA, Panico MDB, Porto CLL, Milhomens AL de M, Vieira J de M. Venous thromboembolism prophylaxis on flight. Vol. 17, Jornal Vascular Brasileiro. 2018.
  946. Johnston R v, Hudson MF, Aerospace Medical Association Air Transport Medicine Committe. Travelers' thrombosis. Aviat Space Environ Med. 2014 Feb;85(2).
  947. Cesarone MR, Belcaro G, Nicolaides AN, Incandela L, de Sanctis MT, Geroulakos G, et al. Venous thrombosis from air travel: The LONFLIT3 study: Prevention with aspirin vs low-molecular-weight heparin )LMWH( in high-risk subjects: A randomized trial. Angiology. 2002;53(1).
  948. Clarke MJ, Broderick C, Hopewell S, Juszczak E, Eisinga A. Compression stockings for preventing deep vein thrombosis in airline passengers. Vol. 2016, Cochrane Database of Systematic Reviews. 2016.
  949. Martinez I. Aircraft Environmental Control, 1995-2020.
  950. Mangili A, Vindenes T, Gendreau M. Infectious Risks of Air Travel. Microbiology Spectrum. 2015;3(5).
  951. Hertzberg VS, Weiss H, Elon L, Si W, Norris SL. Behaviors, movements, and transmission of droplet- mediated respiratory diseases during transcontinental airline flights. Proc Natl Acad Sci U S A. 2018;115(14).
  952. Olsen SJ, Chang HL, Cheung TYY, Tang AFY, Fisk TL, Ooi SPL, et al. Transmission of the Severe Acute Respiratory Syndrome on Aircraft. New England Journal of Medicine. 2003;349(25).
  953. WHO. Tuberculosis and Air Travel: Guidelines for prevention and control. 3rd ed. Geneva: WHO; 2013.
  954. Jost M, Luzi D, Metzler S, Miran B, Mutsch M. Measles associated with international travel in the region of the Americas, Australia and Europe, 2001-2013: A systematic review. Vol. 13, Travel Medicine and Infectious Disease. 2015.
  955. Bhuvan KC, Shrestha R, Leggat PA, Ravi Shankar P, Shrestha S. Safety of air travel during the ongoing COVID-19 pandemic. Travel Med Infect Dis. 43.
  956. Grimholt TK, Bonsaksen T, Schou-Bredal I, Heir T, Lerdal A, Skogstad L, et al. Flight anxiety reported from 1986 to 2015. Aerospace Medicine and Human Performance. 2019;90(4).
  957. Schindler B, Vriends N, Margraf J, Stieglitz RD. WAYS of ACQUIRING FLYING PHOBIA. Depression and Anxiety. 2016;33(2).
  958. Campos D, Breton-Lopez J, Botella C, Mira A, Castilla D, Mor S, et al. Efficacy of an internet-based exposure treatment for flying phobia (NO-FEAR Airlines) with and without therapist guidance: A randomized controlled trial. BMC Psychiatry. 2019;19(1).
  959. British Thoracic Society. Air Travel. 2020.
  960. Isakov A. Management of inflight medical events on commercial airlines.
  961. Koh AS, Ross LK. Mental health issues: A comparison of lesbian, bisexual and heterosexual women. Journal of Homosexuality. 2006;51(1).
  962. King M, Semlyen J, Tai SS, Killaspy H, Osborn D, Popelyuk D, et al. A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. Vol. 8, BMC Psychiatry. 2008.
  963. Cochran SD, Bandiera FC, Mays VM. Sexual orientation-related differences in tobacco use and secondhand smoke exposure among US adults aged 20 to 59 years: 2003-2010 National Health and Nutrition Examination Surveys. Vol. 103, American Journal of Public Health. 2013.
  964. Riggle EDB, Rostosky SS, Reedy CS. Online surveys for BGLT research: Issues and techniques. Vol. 49, Journal of Homosexuality. 2005.
  965. Institute of Medicine )US( Committee on Lesbian GB and THI and RG and O. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington DC: National Academies Press; 2011.
  966. Buchmueller T, Carpenter CS. Disparities in health insurance coverage, access, and outcomes for individuals in same-sex versus different-sex relationships, 2000-2007. American Journal of Public Health. 2010;100(3).
  967. Gates GJ. LGBT Demographics: Comparisons among population-based surveys Executive Summary. The Williams Institute. 2014;)October).
  968. Zhang Q, Goodman M, Adams N, Corneil T, Hashemi L, Kreukels B, et al. Epidemiological considerations in transgender health: A systematic review with focus on higher quality data. International Journal of Transgender Health. 2020;21(2).
  969. Arcelus J, Bouman WP, van den Noortgate W, Claes L, Witcomb G, Fernandez-Aranda F. Systematic Review and Meta-Analysis of Prevalence Studies in Transsexualism. European Psychiatry. 2015 Sep 26;30)6(:807-15.
  970. Committee opinion no. 525: Health care for lesbians and bisexual women. Vol. 119, Obstetrics and Gynecology. 2012.
  971. Knight DA, Jarrett D. Preventive health care for men who have sex with men. American Family Physician. 2015;91(12).
  972. McNair RP, Hegarty K. Guidelines for the primary care of lesbian, gay, and bisexual people: A systematic review. Vol. 8, Annals of Family Medicine. 2010.
  973. Knight DA, Jarrett D. Preventive health care for women who have sex with women. American Family Physician. 2017;95(5).
  974. U.S. Preventive Services Task Force. Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions (Internet). 2015 (cited 2021 Nov 17). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and- pregnant-women-counseling-and-interventions-september-2015
  975. Goldbach JT, Tanner-Smith EE, Bagwell M, Dunlap S. Minority Stress and Substance Use in Sexual Minority Adolescents: A Meta-analysis. Vol. 15, Prevention Science. 2014.
  976. Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents. JAMA. 2020 Apr 28;323)16(:1590.
  977. U.S. Preventive Services Task Force. Depression in Children and Adolescents: Screening (Internet). 2016 (cited 2021 Nov 18). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/depression- in-children-and-adolescents-screening
  978. U.S. Preventive Services Task Force. Sexually Transmitted Infections: Behavioral Counseling (Internet). 2020 (cited 2021 Nov 18). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/sexually-transmitted- infections-behavioral-counseling
  979. GLMA. Guidelines for Care of Lesbian, Gay, Bisexual, and Transgender Patients (Internet). 2011 (cited 2021 Nov 18(. Available from: http://www.glma.org/ data/n 0001/resources/live/GLMA%20guidelines%202006%20FINALpdf
  980. Barker JC. Neighbors, friends, and other nonkin caregivers of community-living dependent elders. Journals of Gerontology - Series B Psychological Sciences and Social Sciences. 2002;57(3).
  981. Shippy R, Cantor M, Brennan M. Social Networks of Aging Gay Men. The Journal of Men's Studies. 2004;13(1).
  982. Feltner C, Wallace I, Berkman N, Kistler CE, Middleton JC, Barclay C, et al. Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA - Journal of the American Medical Association. 2018;320(16).
  983. Gelman M, van Wagenen A, Potter J. Principles for taking an LGBTQ-inclusive health history and conducting a culturally competent physical exam. In: Makadon H, Mayer K, Potter J, Goldhammer H, editors. The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health. 2nd ed. Philadelphia: American College of Physicians; 2015. p. 159-92.
  984. Boehmer U, Miao X, Maxwell NI, Ozonoff A. Sexual minority population density and incidence of lung, colorectal and female breast cancer in California. BMJ Open. 2014;4(3).
  985. Clavelle K, King D, Bazzi AR, Fein-Zachary V, Potter J. Breast Cancer Risk in Sexual Minority Women during Routine Screening at an Urban LGBT Health Center. Women's Health Issues. 2015;25(4).
  986. Mays VM, Cochran SD. Mental health correlates of perceived discrimination among lesbian, gay, and bisexual adults in the United States. American Journal of Public Health. 2001;91(11).
  987. Boehmer U, Bowen DJ, Bauer GR. Overweight and obesity in sexual-minority women: Evidence from population-based data. American Journal of Public Health. 2007;97(6).
  988. Marrazzo JM, Stine K, Koutsky LA. Genital human papillomavirus infection in women who have sex with women: A review. American Journal of Obstetrics and Gynecology. 2000;183(3).
  989. McRee AL, Katz ML, Paskett ED, Reiter PL. HPV vaccination among lesbian and bisexual women: Findings from a national survey of young adults. Vaccine. 2014;32(37).
  990. Jackson CL, Agenor M, Johnson DA, Austin SB, Kawachi I. Sexual orientation identity disparities in health behaviors, outcomes, and services use among men and women in the United States: A cross-sectional study. BMC Public Health. 2016;16(1).
  991. Eliason MJ, Fogel SC. An Ecological Framework for Sexual Minority Women's Health: Factors Associated With Greater Body Mass. Journal of Homosexuality. 2015;62(7).
  992. Everett BG. Sexual orientation disparities in sexually transmitted infections: Examining the intersection between sexual identity and sexual behavior. Archives of Sexual Behavior. 2013;42(2).
  993. Marrazzo JM, Gorgos LM. Emerging sexual health issues among women who have sex with women. Vol. 14, Current Infectious Disease Reports. 2012.
  994. Daskalakis D, Radix A, Mayer G. Sexual health of LGBTQ people. In: Makadon H, Mayer K, Potter J, Goldhammer H, editors. The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health. 2nd ed. Philadelphia: American College of Physicians; 2015. p. 271-324.
  995. Gartrell N, Bos H. US national longitudinal lesbian family study: Psychological adjustment of 17-year-old adolescents. Pediatrics. 2010;126(1).
  996. Mayer KH, Bekker LG, Stall R, Grulich AE, Colfax G, Lama JR. Comprehensive clinical care for men who have sex with men: An integrated approach. Vol. 380, The Lancet. 2012.
  997. Knight D. Health Care Screening for Men Who Have Sex with Men. Vol. 69, American Family Physician. 2004.
  998. Wilkin T. Primary Care for Men Who Have Sex with Men. New England Journal of Medicine. 2015;373(9).
  999. US Preventive Services Task Force. A & B Recommendations (Internet). (cited 2021 Dec 14). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
  1000. O'Connor EA, Lin JS, Burda BU, Henderson JT, Walsh ES, Whitlock EP. Behavioral sexual risk-reduction counseling in primary care to prevent sexually transmitted infections: A systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2014;161(12).
  1001. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports. 2015;64(3).
  1002. European Centre for Disease Prevention and Control. HIV and STI prevention among men who have sex with men (Internet). 2015 (cited 2021 Nov 24). Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/hiv-sti-prevention- among-men-who-have-sex-with-men-guidance.pdf
  1003. Nanduri S, Foo C, Ngo V, Jarashow C, Civen R, Schwartz B, et al. Outbreak of Serogroup C Meningococcal Disease Primarily Affecting Men Who Have Sex with Men — Southern California, 2016. MMWR Morbidity and Mortality Weekly Report. 2016;65(35).
  1004. Zucker J, Layton M. Update: Invasive meningococcal disease in men who have sex with men, four new cases reported in 2013, expanded vaccine recommendations. New York: New York City Department of Health and Mental Hygiene; 2013.
  1005. Allen O. Lesbian Gay & Bisexual Patients: the issues for General Practice. ICGP Quality in Practice Committee; 2013.
  1006. Guideline ACP. Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update: a clinical practice guideline. Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update: a clinical practice guideline. 2017.
  1007. משרד הבריאות. הנחיות למניעת הדבקה ב-HIV לאחר חשיפה לדם או לאחר יחסי מין לא מוגנים (Internet). 05/2010 Sep 13, 2010. Available from: https://www.health.gov.il/hozer/bz05_2010.pdf
  1008. טבע, הוועד למלחמה באיידס, החברה הישראלית לרפואת איידס. אמטריביר טבע: חוברת מידע רפואי לצוות הרפואי (Internet). 2017 (cited 2022 Feb 21). Available from: https://www.health.gov.il/UnitsOffice/HD/MTI/Drugs/risk/DocLib/HIV_a6_stuff.pdf
  1009. Safer JD, Tangpricha V. Care of Transgender Persons. New England Journal of Medicine. 2019 Dec 19;381)25(:2451-60.
  1010. Klein DA, Paradise SL, Goodwin ET. Caring for transgender and gender-diverse persons: What clinicians should know. American Family Physician. 2018;98(11).
  1011. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/ gender-incongruent persons: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2017;102(11).
  1012. Adams PC, Arthur MJ, Boyer TD, DeLeve LD, di Bisceglie AM, Hall M, et al. Screening in Liver Disease: Report of an AASLD Clinical Workshop. In: Hepatology. 2004.
  1013. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002 Nov;36)5B(:s35-46.
  1014. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36)S1).
  1015. Recommendations for prevention and control of hepatitis C virus )HCV( infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 1998;47)RR-19).
  1016. Alter MJ. Epidemiology and prevention of hepatitis B. Vol. 23, Seminars in Liver Disease. 2003.
  1017. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: Evolving epidemiology and implications for control. Vol. 11, Seminars in Liver Disease. 1991.
  1018. Fattovich G. Natural history and prognosis of hepatitis B. Vol. 23, Seminars in Liver Disease. 2003.
  1019. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4).
  1020. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, et al. Hemochromatosis and iron overload screening )HEIRS( Study design for an evaluation of 100,000 primary care-based adults. American Journal of the Medical Sciences. 2003;325(2).
  1021. Bancroft WH. Hepatitis A Vaccine. New England Journal of Medicine. 1992 Aug 13;327)7(:488-90.
  1022. Tilzey AJ, Banatvala JE. Hepatitis A. BMJ. 1991 Jun 29;302)6792).
  1023. Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (Internet). Vol. 45, MMWR. 1996 (cited 2021 Dec 14). p. 1-30. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00048084.htm
  1024. Green M, Cohen D, Lerman Y, Sjogren M, Binn L, Zur S, et al. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. Israel Journal of Medical Sciences. 1994;30)5-6(:485-8.
  1025. Bader TF. Hepatitis A vaccine: Who should use it? Vol. 14, Infections in Medicine. 1997.
  1026. Krause DS. Hepatitis A vaccines. JAMA. 1996 Aug 14;276)6(:449-50.
  1027. Hastings G, MacFadyen L, Stead M. Tobacco marketing: Shackling the pied piper. To stop the young from smoking we must move beyond advertising bans. Vol. 315, British Medical Journal. 1997.
  1028. Davis RM. Passive smoking: History repeats itself. Vol. 315, British Medical Journal. 1997.
  1029. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. British Medical Journal. 1997;315)7114).
  1030. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The Primary Prevention of Coronary Heart Disease in Women. New England Journal of Medicine. 1995 Jun 29;332)26(:1758-66.
  1031. Powell KE, Pratt M. Physical activity and health. BMJ. 1996 Jul 20;313)7050(:126-7.
  1032. Jones TF, Eaton CB. Exercise prescription. Am Fam Physician. 1995 Aug;52)2(:543-50, 553-5.
  1033. Chiang KF, Shah SJ, Stafford RS. A Practical Approach to Low-Dose Aspirin for Primary Prevention. JAMA. 2019 Jul 23;322(4):301.
  1034. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: An update. Vol. 36, Stroke. 2005.
  1035. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, et al. Randomised trial of prophylactic daily aspirin in British male doctors. British Medical Journal )Clinical research ed). 1988;296)6618).
  1036. Physicians' Health Study: Aspirin and Primary Prevention of Coronary Heart Disease. New England Journal of Medicine. 1989;321(26).
  1037. יודפת י. האם נפתרה השאלה "האם קיימת הצדקה לטיפול באספירין במניעה ראשונית." כתב העת הישראלי לרפואת המשפחה 5:)164(21;2011 .
  1038. אספירין למניעה ראשונית של מחלות קרדיווסקולריות - נייר עמדה - Aspirin for primary prevention of cardiovascular disease
  1039. US Preventive Services Task Force. Final Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication (Internet). 2016 (cited 2021 Dec 19[. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer
  1040. McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. New England Journal of Medicine. 2018;379(16).
  1041. McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, et al. Effect of Aspirin on Disability-free Survival in the Healthy Elderly. New England Journal of Medicine. 2018;379(16).
  1042. The ASCEND Study Collaborative, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, et al. The ASCEND Study Collaborative Group. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. New England Journal of Medicine. 2018;379(16).
  1043. Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. The Lancet. 2018;392)10152).
  1044. Zheng SL, Roddick AJ. Association of Aspirin Use for Primary Prevention with Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis. Vol. 321, JAMA - Journal of the American Medical Association. 2019.
  1045. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. New England Journal of Medicine. 2018;379(16).
  1046. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. The Lancet. 2010 Nov;376)9754(:1741-50.
  1047. Rothwell PM, Fowkes FGR, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials. The Lancet. 2011;377)9759).
  1048. Hull MA, Sprange K, Hepburn T, Tan W, Shafayat A, Rees CJ, et al. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas )seAFOod Polyp Prevention trial(: a multicentre, randomised, double-blind, placebo-controlled, 2 x 2 factorial trial. The Lancet. 2018;392)10164).
  1049. Okada S, Morimoto T, Ogawa H, Sakuma M, Matsumoto C, Soejima H, et al. Effect of aspirin on cancer chemoprevention in Japanese patients with type 2 diabetes: 10-year observational follow-up of a randomized controlled trial. In: Diabetes Care. 2018.
  1050. Cuzick J. First results from the International Breast Cancer Intervention Study )IBIS-I(: A randomised prevention trial. Lancet. 2002;360)9336).
  1051. DeCensi A, Bonanni B, Maisonneuve P, Serrano D, Omodei U, Varricchio C, et al. A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: The HOT study. Annals of Oncology. 2013;24(11).
  1052. Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, et al. Tamoxifen for prevention of breast cancer: Extended long-term follow-up of the IBIS-I breast cancer prevention trial. The Lancet Oncology. 2015;16(1).
  1053. Li F, Dou J, Wei L, Li S, Liu J. The selective estrogen receptor modulators in breast cancer prevention. Vol. 77, Cancer Chemotherapy and Pharmacology. 2016.
  1054. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation ]see comments[. JAMA. 1999;281(23).
  1055. Lippman ME, Cummings SR, Disch DP, Mershon JL, Dowsett SA, Cauley JA, et al. Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk. Clinical Cancer Research. 2006;12(17).
  1056. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Update of the national surgical adjuvant breast and bowel project Study of Tamoxifen and Raloxifene )STAR( P-2 trial: Preventing breast cancer. Cancer Prevention Research. 2010;3(6).
  1057. Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, et al. Lasofoxifene in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 2010;362(8).
  1058. Cummings SR, McClung M, Reginster JY, Cox D, Mitlak B, Stock J, et al. Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women. Journal of Bone and Mineral Research. 2011;26(2).
  1059. Nelson HD, Fu R, Zakher B, Pappas M, McDonagh M. Medication Use for the Risk Reduction of Primary Breast Cancer in Women. JAMA. 2019;322(9).
  1060. U.S. Preventive ServicesTaskForce. Breast Cancer: Medication Use to Reduce Risk: FinalRecommendation Statement (Internet). 2019 (cited 2021 Dec 20). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone- therapy-preventive-medication
  1061. NCCN. National Comprehensive Cancer Guidelines.
  1062. Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, et al. Exemestane for Breast-Cancer Prevention in Postmenopausal Women. New England Journal of Medicine. 2011;364(25).
  1063. Mocellin S, Pilati P, Briarava M, Nitti D. Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. JNCI: Journal of the National Cancer Institute. 2016 Feb;108(2).
  1064. Baill IC, Castiglioni A. Health Maintenance in Postmenopausal Women. Vol. 95, American family physician. 2017.
  1065. Crew KD, Albain KS, Hershman DL, Unger JM, Lo SS. How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? npj Breast Cancer. 2017;3(1).
  1066. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture Prevention With Vitamin D Supplementation. JAMA. 2005;293(18).
  1067. Alvarez-Leon EE, Roman-Vinas B, Serra-Majem L. Dairy products and health: a review of the epidemiological evidence. British Journal of Nutrition. 2006;96)S1).
  1068. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a comparative metaanalysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism. 2007;92(4).
  1069. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal Vitamin D Status for Colorectal Cancer Prevention. A Quantitative Meta Analysis. American Journal of Preventive Medicine. 2007;32(3).
  1070. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels )Finland). Cancer Causes and Control. 2000;11(9).
  1071. Hochwald O, Harman-Boehm I, Castel H. Hypovitaminosis D among inpatients in a sunny country. Israel Medical Association Journal. 2004;6(2).
  1072. Holick MF. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. In: American Journal of Clinical Nutrition. 2004.
  1073. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: A review. Vol. 10, Alternative Medicine Review. 2005.
  1074. Holick MF. Vitamin D Deficiency. New England Journal of Medicine. 2007 Jul 19;357(3).
  1075. Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. In: Journal of Steroid Biochemistry and Molecular Biology. 2004.
  1076. Hanley DA, Davison KS. Symposium: Vitamin D Insufficiency: A Significant Risk Factor in Chronic Diseases and Potential Disease-Specific Biomarkers of Vitamin D Sufficiency Vitamin D Insufficiency in North America 1. J Nutr. 2005;135.
  1077. Fiscella K, Franks P. Vitamin D, Race, and Cardiovascular Mortality: Findings From a National US Sample. The Annals of Family Medicine. 2010 Jan 1;8)1(:11-8.
  1078. Heaney RP. Vitamin D in health and disease. Clinical Journal of the American Society of Nephrology. 2008;3(5).
  1079. Wood AJJ, Riggs BL, Melton LJ. The Prevention and Treatment of Osteoporosis. New England Journal of Medicine. 1992 Aug 27;327)9(:620-7.
  1080. Miller PD, Zapalowski C, Kulak CAM, Bilezikian JP. Bone densitometry: The best way to detect osteoporosis and to monitor therapy. Vol. 84, Journal of Clinical Endocrinology and Metabolism. 1999.
  1081. Mebane-Sims I. Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions )PEPI( trial. J Am Med Assoc. 1996;276(17).
  1082. Mendelsohn ME, Karas RH. The Protective Effects of Estrogen on the Cardiovascular System. New England Journal of Medicine. 1999;340(23).
  1083. Ettinger B. Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE> JAMA. 1999 Aug 18;282)7(:637.
  1084. פינס ע. טיפול הורמוני חלופי בגיל חדילת-אורח למניעת מחלות לב - החלום שנגוז? הרפואה (Internet). 2003 Mar (cited 2021 Dec 20); Available from: https://www.ima.org.il/Medicine/Download.aspx?fi=7183
  1085. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis. New England Journal of Medicine. 2000;343(8).
  1086. Poulter N. Oestrogen and protection against cardiovascular disease: Potential versus reality. Vol. 8, British Journal of Cardiology. 2001.
  1087. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. J Am Med Assoc. 2002;288(3).
  1088. Stevenson JC, Whitehead MI. Hormone replacement therapy: Findings of women's health initiative trial need not alarm users. Vol. 325, BMJ. 2002.
  1089. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, et al. Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women. JAMA. 2003;289)24).
  1090. Li CI, Malone KE, Porter PL, Weiss NS, Tang MTC, Cushing-Haugen KL, et al. Relationship between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer. J Am Med Assoc. 2003;289)24).
  1091. Gann PH, Morrow M. Combined Hormone Therapy and Breast Cancer: A Single-Edged Sword. Vol. 289, Journal of the American Medical Association. 2003.
  1092. Brewer D, Nashelsky J, Hansen LB. What nonhormonal therapies are effective for postmenopausal vasomotor symptoms? Vol. 52, Journal of Family Practice. 2003.
  1093. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of Estrogen plus Progestin on Health-Related Quality of Life. New England Journal of Medicine. 2003;348(19).
  1094. Rymer J, Wilson R, Ballard K. Making decisions about hormone replacement therapy. Vol. 326, British Medical Journal. 2003.
  1095. Petitti DB. Hormone replacement therapy for prevention: More evidence, more pessimism. Vol. 288, Journal of the American Medical Association. 2002.
  1096. Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. Vol. 288, Journal of the American Medical Association. 2002.
  1097. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal Estrogen Therapy and Cardiovascular Disease. New England Journal of Medicine. 1991 Sep 12;325)11(:756-62.
  1098. Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease. New England Journal of Medicine. 1996;335(18).
  1099. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. J Am Med Assoc. 2000;283(4).
  1100. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000;92(4).
  1101. Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. J Am Med Assoc. 2002;287(6).
  1102. Merom D, Ifrah A, Cohen-Manheim I, Chinich A, Green MS. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998. Israel Medical Association Journal. 2002;4(9).
  1103. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: Scientific review. Vol. 288, Journal of the American Medical Association. 2002.
  1104. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: A meta-analysis. Vol. 79, Obstetrics and Gynecology. 1992.
  1105. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. American Journal of Obstetrics and Gynecology. 1993;168(5).
  1106. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, et al. Noncardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy. JAMA. 2002;288(1).
  1107. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy. JAMA. 2002;288(1).
  1108. Wassertheil-Smoller S, Hendrix S, Limacher M, Heiss G, Kooperberg C, Baird A, et al. Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women. JAMA. 2003;289)20).
  1109. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JAE, et al. Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women - The Women's Health Initiative Memory Study: A Randomized Controlled Trial. J Am Med Assoc. 2003;289)20).
  1110. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women. JAMA. 2003;289)20).
  1111. Roberts H. Managing the menopause. BMJ. 2007 Apr 7;334)7596(:736-41.
  1112. LaCroix AZ. Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy. JAMA. 2011 Apr 6;305)13(:1305.
  1113. משרד הבריאות ההלמ. מצב הבריאות בישראל, 65-352 .202. 1997.
  1114. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions )PEPI( Trial. The Writing Group for the PEPI Trial. JAMA. 1995 Jan 18;273)3(:199-208.
  1115. רוזנפלד, קיצס-כהן, גולדשמיד. יתרונות וחסרונות הטיפול ההורמונלי התחליפי: עידכון. תרפיה שימושית 1994 .
  1116. Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, et al. The Effects of Tibolone in Older Postmenopausal Women. New England Journal of Medicine. 2008;359(7).
  1117. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Vol. 2017, Cochrane Database of Systematic Reviews. 2017.
  1118. US Preventive Services Task Force. Final Recommendation Statement: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions. 2017.
  1119. הטיפול באישה בגיל המעבר - נייר עמדה
  1120. NICE. Menopause: diagnosis and management. Women's Health (Internet). 2019 Dec 18 (cited 2021 Dec 20); Available from: https://www.guidelines.co.uk/womens-health/nice-menopause-guideline/252685.article
  1121. Segarra TJ, Ritchie M, Zehtabchi S. Hormone therapy for primary prevention of cardiovascular disease in postmenopausal women. Vol. 98, American Family Physician. 2018.
  1122. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older. New England Journal of Medicine. 1997;337(10).
  1123. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis. New England Journal of Medicine. 1990;322(18).
  1124. van Staa TP, Abenhaim L, Cooper C. Use of cyclical etidronate and prevention of non-vertebral fractures. Rheumatology. 1998 Jan 1;37)1(:87-94.
  1125. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, et al. Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis. New England Journal of Medicine. 1995;333(22).
  1126. Screening for osteoporosis : No point until we have resolved issues about long term treatment. BMJ: British Medical Journal. 1999;319)7218).
  1127. Lindsay R, Cosman F, Lobo RA, Walsh BW, Harris ST, Reagan JE, et al. Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial. Journal of Clinical Endocrinology and Metabolism. 1999;84(9).
  1128. Furesz J, Scheifele DW, Palkonyay L. Safety and effectiveness of the new inactivated hepatitis A virus vaccine. Vol. 152, CMAJ. 1995.
  1129. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. Journal of Bone and Mineral Research. 2002;17(1).
  1130. Delmas PD. Treatment of postmenopausal osteoporosis. The Lancet. 2002 Jun;359)9322(:2018-26.
  1131. Riggs BL, Hartmann LC. Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice. New England Journal of Medicine. 2003;348(7).
  1132. Santoro NF. Where Are We Going? The Journal of Clinical Endocrinology & Metabolism. 1999 Jun 1;84)6(:1798-9.
  1133. Barrett-Connor E, Stuenkel C. Hormones and Heart Disease in Women: Heart and Estrogen/Progestin Replacement Study in Perspective. The Journal of Clinical Endocrinology & Metabolism. 1999 Jun;84)6(:1848-53.
  1134. Nelson HD. Osteoporosis and Fractures in Postmenopausal Women Using Estrogen. Archives of Internal Medicine. 2002 Nov 11;162)20(:2278.
  1135. Kleerekoper M. Lessons from the skeleton: Was the Women's Health Initiative )WHI( a primary prevention trial? Vol. 13, Osteoporosis International. 2002.
  1136. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, et al. Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 2002 Aug;87)8(:3609-17.
  1137. Siris E, Adachi JD, Lu Y, Fuerst T, Crans GG, Wong M, et al. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: Results from the MORE study. Osteoporosis International. 2002;13(11).
  1138. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of Parathyroid Hormone )1-34( on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 2001;344(19).
  1139. NIH Consensus Development Panel on Osteoporosis Prevention D and T. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA: The Journal of the American Medical Association. 2001 Feb 14;285)6(:785- 95.
  1140. Harrington JT, Ste-Marie LG, Brandi ML, Civitelli R, Fardellone P, Grauer A, et al. Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis. Calcified Tissue International. 2004 Apr 1;74)2(:129-35.
  1141. Aguilar I, Berger ZD, Casher D, Choi RY, Green JB, Harding EG, et al. The "top 5" lists in primary care: Meeting the responsibility of professionalism. Archives of Internal Medicine. 2011;171(15).
  1142. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: An update for the U.S. Preventive Services Task Force. Vol. 153, Annals of Internal Medicine. 2010.
  1143. Kanis JA. WHO Scientific Group Technical Report: Assessment of osteoporosis at the primary health care level. University of Sheffield. 2007.
  1144. Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ. Trends in fracture incidence: A population-based study over 20 years. Journal of Bone and Mineral Research. 2014;29(3).
  1145. Schuit SCE, van der Klift M, Weel AEAM, de Laet CEDH, Burger H, Seeman E, et al. Fracture incidence and association with bone mineral density in elderly men and women: The Rotterdam Study. Bone. 2004;34(1).
  1146. AACE. Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2020 Update (Internet). (cited 2021 Dec 21). Available from: https://pro.aace.com/disease-state-resources/bone-and-parathyroid/clinical-practice-guidelines/clinical- practice
  1147. WHO. WHO SCIENTIFIC GROUP ON THE ASSESSMENT OF OSTEOPOROSIS AT PRIMARY HEALTH CARE LEVEL (Internet). Brussels; (cited 2021 Dec 21). Available from: https://www.sheffield.ac.uk/FRAX/pdfs/WHO Technical Report.pdf
  1148. משרד הבריאות. סל שירותי הבריאות הקבוע בחוק (חוק ביטוח בריאות ממלכתי, תשנ"ד - 1994)‏(Internet), Available from: https://call.gov.il/infocenter/index?page=content&id=N15
  1149. NIH. Study of Tamoxifen and Raloxifene )STAR( for the Prevention of Breast Cancer in Postmenopausal Women (Internet). ClinicalTrials.gov. 2003 (cited 2021 Dec 21). Available from: https://clinicaltrials.gov/ct2/show/NCT00003906
  1150. Black D, et al. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis. The New England Journal of Medicine (Internet). 2007 May 3 (cited 2021 Dec 21);356(18):1809-22. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa067312
  1151. Cardwell CR, Abnet CC, Cantwell MM, Murray LJ. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA - Journal of the American Medical Association. 2010;304(6).
  1152. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. J Am Med Assoc. 1999;282(14).
  1153. Reginster JY, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporosis International. 2000;11(1).
  1154. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture intervention trial. J Am Med Assoc. 1998;280)24).
  1155. Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 2009;361(8).
  1156. Miller PD, Bolognese MA, Lewiecki EM, McClung MR, Ding B, Austin M, et al. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial. Bone. 2008;43(2).
  1157. McClung MR, Lewiecki EM, Geller ML, Bolognese MA, Peacock M, Weinstein RL, et al. Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial. Osteoporosis International. 2013;24(1).
  1158. Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, et al. The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: Results from the FREEDOM extension. Journal of Clinical Endocrinology and Metabolism. 2013;98(11).
  1159. Watts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, et al. Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? Osteoporosis International. 2012 Jan 3;23)1(:327-37.
  1160. Chesnut CH, Silverman S, Andriano K, Genant H, Gimona A, Harris S, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. American Journal of Medicine. 2000;109(4).
  1161. Cauley JA. Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE> JAMA. 2003 Oct 1;290)13(:1729.
  1162. Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, et al. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: Results from the women's health initiative randomized trial. Journal of Bone and Mineral Research. 2006;21(6).
  1163. Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone )1-34( for 2 years and relevance to human safety. Toxicologic Pathology. 2002;30(3).
  1164. Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, et al. One Year of Alendronate after One Year of Parathyroid Hormone )1-84( for Osteoporosis. New England Journal of Medicine. 2005;353(6).
  1165. Reginster JY. Cardiac concerns associated with strontium ranelate. Vol. 13, Expert Opinion on Drug Safety. 2014.
  1166. Carmel AS, Shieh A, Bang H, Bockman RS. The 25)OH(D level needed to maintain a favorable bisphosphonate response is >33 ng/ml. Osteoporosis International. 2012;23(10).
  1167. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin d levels and bone mineral density: a population-based study of younger and older adults. The American Journal of Medicine. 2004 May;116)9(:634-9.
  1168. Ross AC, Manson JAE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. Vol. 96, Journal of Clinical Endocrinology and Metabolism. 2011.
  1169. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. Vol. 96, Journal of Clinical Endocrinology and Metabolism. 2011.
  1170. Wimalawansa SJ. Vitamin D in the new millennium. Current Osteoporosis Reports. 2012;10(1).
  1171. Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, et al. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. New England Journal of Medicine. 2015;373(16).
  1172. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International. 1997;7(5).
  1173. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus Vitamin D Supplementation and the Risk of Fractures. New England Journal of Medicine. 2006;354(7).
  1174. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of Vitamin D on Falls: A Meta-analysis. Vol. 291, Journal of the American Medical Association. 2004.
  1175. Bischoff-Ferrari HA, Conzelmann M, Stahelin HB, Dick W, Carpenter MG, Adkin AL, et al. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporosis International. 2006;17(5).
  1176. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. Journal of Bone and Mineral Research. 2000;15(6).
  1177. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Archives of Internal Medicine. 2007;167(16).
  1178. Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporosis International. 2016;27(1).
  1179. Silverman SL, Cummings SR, Watts NB. Recommendations for the clinical evaluation of agents for treatment of osteoporosis: Consensus of an expert panel representing the American Society for Bone and Mineral Research )ASBMR(, the International Society for Clinical Densitometry )ISCD(, and the National Osteoporosis Foundation )NOF). Journal of Bone and Mineral Research. 2008;23(1).
  1180. Alaimo K, McDowell MA, Briefel RR, Bischof AM, Caughman CR, Loria CM, et al. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data. 1994;)258).
  1181. אוסטיאופורוזיס בקרב מבוגרים - אבחון, מניעה וטיפול - נייר עמדה 2012
  1182. U.S. Preventive Services Task Force. Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions: Final Recommendation Statement (Internet). 2017 (cited 2022 Feb 21). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/menopausal- hormone-therapy-preventive-medication
  1183. Silverman SL, Cummings SR, Watts NB. Recommendations for the Clinical Evaluation of Agents for Treatment of Osteoporosis: Consensus of an Expert Panel Representing the American Society for Bone and Mineral Research )ASBMR(, the International Society for Clinical Densitometry )ISCD(, and the. Journal of Bone and Mineral Research. 2007 Sep 10;23)1(:159-65.
  1184. עמותת עילא. עמוד הבית (Internet). (cited 2022 Feb 21). Available from: http://www.bone.org.il/
  1185. U.S. Preventive Services Task Force. Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions: Final Recommendation Statement (Internet). 2017 (cited 2022 Feb 21). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone- therapy-preventive-medication
  1186. Miller PD, Lewiecki EM, Krohn K, Schwartz E. Teriparatide: Label changes and identifying patients for long-term use. Cleveland Clinic Journal of Medicine. 2021 Sep 1;88(9).
  1187. Shemesh A. Data from ICBS/MOH National Health Survey, 2003-4. Personal communication. 2006.
  1188. Brown FC, Buboltz WC, Soper B. Relationship of sleep hygiene awareness, sleep hygiene practices, and sleep quality in university students. Behavioral Medicine. 2002;28(1).
  1189. Jefferson CD, Drake CL, Scofield HM, Myers E, McClure T, Roehrs T, et al. Sleep hygiene practices in a population-based sample of insomniacs. Vol. 28, Sleep. 2005.
  1190. Basner RC. Continuous Positive Airway Pressure for Obstructive Sleep Apnea. New England Journal of Medicine. 2007 Apr 26;356)17(:1751-8.
  1191. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27(3).
  1192. Milner CE, Cote KA. Benefits of napping in healthy adults: Rmpact of nap length, time of day, age, and experience with napping. Journal of Sleep Research. 2009;18(2).
  1193. Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended amount of sleep for a healthy adult: A joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. In: Sleep. 2015.
  1194. Paruthi S, Brooks LJ, D'Ambrosio C, Hall WA, Kotagal S, Lloyd RM, et al. Recommended amount of sleep for pediatric populations: A consensus statement of the American Academy of Sleep Medicine. Journal of Clinical Sleep Medicine. 2016;12(6).
  1195. למ"ס. לוח 20: בני 20 ומעלה, לפי שעות שינה ביממה ובעיות בשינה ולפי תכונות נבחרות כולל נושא ייחודי: בריאות ואורח חיים (Internet). (cited 2021 Dec 22). Available from: https://www.cbs.gov.il/he/publications/doclib/2019/seker hevrati17 1761Zt20.pdf
  1196. Bioulac S, Micoulaud Franchi JA, Arnaud M, Sagaspe P, Moore N, Salvo F, et al. Risk of motor vehicle accidents related to sleepiness at the wheel: A systematic review and meta-analysis. Vol. 40, Sleep. 2017.
  1197. Thakkar MM, Sharma R, Sahota P. Alcohol disrupts sleep homeostasis. Vol. 49, Alcohol. 2015.
  1198. Green A, Cohen-Zion M, Haim A, Dagan Y. Evening light exposure to computer screens disrupts human sleep, biological rhythms, and attention abilities. Chronobiology International. 2017;34(7).
  1199. Kryger MH, Malhotra A. Management of obstructive sleep apnea in adults (Internet). UpToDate. 2021 (cited 2022 Feb 21). Available from: https://www.uptodate.com/contents/management-of-obstructive-sleep-apnea-in-adults
  1200. Chen L, Pivetta B, Nagappa M, Saripella A, Islam S, Englesakis M, et al. Validation of the STOP-Bang questionnaire for screening of obstructive sleep apnea in the general population and commercial drivers: a systematic review and meta-analysis. Vol. 25, Sleep and Breathing. 2021.
  1201. Zhao X, Cheng L, Zhu C, Cen S, Lin W, Zheng W, et al. A double-edged sword: the association of daytime napping duration and metabolism related diseases in a Chinese population. European Journal of Clinical Nutrition. 2021;75(2).
  1202. Smotek M, Farkova E, Mankova D, Koprivova J. Evening and night exposure to screens of media devices and its association with subjectively perceived sleep: Should "light hygiene" be given more attention? Sleep Health. 2020;6(4).
  1203. WHO. Responding to intimate partner violence and sexual violence against women (Internet). 2013 (cited 2021 Dec 22). Available from: https://apps.who.int/iris/bitstream/handle/10665/85240/9789241548595 eng.pdf
  1204. WHO. The World Health Assembly endorses the global plan of action on violence against women and girls, and also against children (Internet). (cited 2021 Dec 22). Available from: https://www.svri.org/svrinterest/world-health-assembly-endorses-global-plan-action-violence-against- women-and-girls-and and also: https://apps.who.int/gb/ebwha/pdf files/WHA74/A74 21-en.pdf
  1205. NICE. Domestic violence and abuse (Internet). 2016 (cited 2021 Dec 23). Available from: https://www.nice.org.uk/guidance/qs116
  1206. National Institute for Health and Care Excellence. Domestic Violence and Abuse: multi-agency working. NICE Guideline. 2014;)February 2014).
  1207. CDC. Connecting the Dots: An Overview of the Links Among Multiple Forms of Violence (Internet). 2014 Jul (cited 2021 Dec 23). Available from: https://www.cdc.gov/violenceprevention/pdf/connecting the dots-a.pdf
  1208. WHO. Global and regional estimates of violence against women (Internet). 2013 Oct (cited 2021 Dec 23). Available from: https://www.who. int/publications/i/item/9789241564625
  1209. WHO. Elder abuse (Internet). 2021 Oct (cited 2021 Dec 23). Available from: https://www.who.int/en/news-room/fact-sheets/detail/elder-abuse
  1210. World Health Organization. Elder abuse (Internet). 2021 (cited 2022 Feb 21). Available from: https://www.who.int/news-room/fact-sheets/detail/elder-abuse
  1211. NISVS, CDC. National Intimate Partner and Sexual Violence Survey: 2015 Data Brief - Updated Release (Internet). 2018 (cited 2021 Dec 23). Available from: https://www.cdc.gov/violenceprevention/pdf/2015data-brief508.pdf
  1212. 2019 משטרת ישראל. השנתון הסטטיסטי של משטרת ישראל לשנת (Internet). 2020 (cited 2021 Dec 23). Available from: https://www.gov.il/he/departments/publications/reports/police statistical abstract 2019
  1213. 2015 מזרחי סימון ש. אלימות כלפי נשים - ריכוז נתונים לשנת (Internet). 2015 Nov (cited 2021 Dec 23). Available from: https://fs.knesset.gov.il/globaldocs/MMM/dd1207dc-1277-e511-80d1-00155d0ad6b2/2 dd1207dc-1277-e511-80d1-00155d0ad6b2 11 9862.pdf
  1214. JDC-Eshel, University of Haifa. The National Survey on Elder Abuse and Neglect in Israel (Internet). 2004 (cited 2021 Dec 23). Available from: http://www.inpea.net/images/Israel NationalSurvey2004.pdf
  1215. איגוד מרכזי הסיוע לנפגעות ולנפגעי תקיפה מינית. נתוני פגיעה מינית לשנת 2018 (Internet). 2019 (cited 2021 Dec 23). Available from: https://www.1202.org.il/images/files/reports/2019-annual/%D7%A4%D7%A8%D7%A7 AA%D7%95%D7%A0%D7%99%D7%9D 2018%D7%A2%D7%91%D7%A8%D7%99%D7%AA.pdf
  1216. Lev-Wiesel R, Eisikovits Z, First M, Gottfried R, Mehlhausen D. Prevalence of Child Maltreatment in Israel: A National Epidemiological Study. Journal of Child & Adolescent Trauma. 2018 Jun 2;11)2(:141-50.
  1217. Steinmetz D, Tabenkin H. ]Screening for domestic violence in primary care setting[. Harefuah. 2008 Dec;147)12(:978-81, 1030, 1029.
  1218. Schein M, Biderman A, Baras M, Bennett L, Bisharat B, Borkan J, et al. The prevalence of a history of child sexual abuse among adults visiting family practitioners in Israel. Child Abuse & Neglect. 2000 May;24)5(:667-75.
  1219. Tsavoussis A, Stawicki SPA, Stoicea N, Papadimos TJ. Child-Witnessed Domestic Violence and its Adverse Effects on Brain Development: A Call for Societal Self-Examination and Awareness. Frontiers in Public Health. 2014 Oct 10;2.
  1220. Guttmacher Institute. Facts on Induced Abortion Worldwide. In: Induced Abortion Worldwide (Internet). WHO; 2012 (cited 2021 Dec 23). Available from: https://www.who.int/reproductivehealth/publications/unsafe abortion/induced abortion 2012.pdf?ua=1
  1221. Trevillion K, Oram S, Feder G, Howard LM. Experiences of Domestic Violence and Mental Disorders: A Systematic Review and Meta-Analysis. PLoS ONE. 2012 Dec 26;7)12(:e51740.
  1222. Norman RE, Byambaa M, De R, Butchart A, Scott J, Vos T. The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis. Vol. 9, PLoS Medicine. 2012.
  1223. Irish L, Kobayashi I, Delahanty DL. Long-term Physical Health Consequences of Childhood Sexual Abuse: A Meta-Analytic Review. Journal of Pediatric Psychology. 2010 Jun 1;35)5(:450-61.
  1224. Chen LP, Murad MH, Paras ML, Colbenson KM, Sattler AL, Goranson EN, et al. Sexual Abuse and Lifetime Diagnosis of Psychiatric Disorders: Systematic Review and Meta-analysis. Mayo Clinic Proceedings. 2010 Jul;85)7(:618-29.
  1225. Lachs MS, Pillemer KA. Elder Abuse. New England Journal of Medicine. 2015 Nov 12;373)20(:1947-56.
  1226. Lachs MS. The Mortality of Elder Mistreatment. JAMA. 1998 Aug 5;280)5(:428.
  1227. WHO. European report on preventing elder maltreatment (Internet). 2011 (cited 2021 Dec 23). Available from: https://www.euro.who.int/ data/assets/pdf file/0010/144676/e95110.pdf
  1228. CDC. Child Abuse and Neglect: Definitions (Internet). 2017 (cited 2021 Dec 23). Available from: https://www.cdc.gov/violenceprevention/childabuseandneglect/index.html
  1229. WHO. Health care for women subjected to intimate partner violence or sexual violence (Internet). 2014 (cited 2021 Dec 23). Available from: http://apps.who.int/iris/bitstream/10665/136101/1/WHO RHR 14.26 eng.pdf?ua=1
  1230. US Preventive Services Task Force. Final Recommendation Statement: Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening (Internet). 2018 (cited 2021 Dec 23). Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence- and-abuse-of-elderly-and-vulnerable-adults-screening
  1231. O'Doherty L, Hegarty K, Ramsay J, Davidson LL, Feder G, Taft A. Screening women for intimate partner violence in healthcare settings. Cochrane Database of Systematic Reviews. 2015 Jul 22;
  1232. איתור וטיפול נשים נפגעות אלימות במשפחה ע"י מטפלים - חוזר משרד הבריאות
  1233. Su WM, Stone L. Adult survivors of childhood trauma: Complex trauma, complex needs. Australian Journal of General Practice (Internet). 2020 (cited 2022 Feb 21);49)7(:423-30. Available from: https://www1 of-childhood-trauma.aspx
  1234. Ravi A, Crescenz CM, Little V. Providing Trauma-Informed Care. American Family Phisician (Internet). 2017 May (cited 2022 Feb 21);95)10(:655-7. Available from: https://www.aafp.org/afp/2017/0515/p655.html
  1235. משרד הבריאות. תקנות למניעת אלימות במשפחה (Internet). 01/03 2003. Available from: https://www.health.gov.il/hozer/mk01 2003.pdf
  1236. Weil A. Intimate partner violence: Intervention and patient management. UpToDate (Internet). 2020 (cited 2021 Dec 23); Available from: https://myvirtualphysician.com/wp-content/uploads/2020/05/Intimate- partner-violence -Diagnosis-and-screening-UpToDate.pdf
  1237. איגוד ומרכזי הסיוע לנפגעות ונפגעי תקיפה מינית. דף הבית (Internet). (cited 2021 Dec 23). Available from: https://www.1202.org.il/
  1238. ההסתדרות הרפואית לישראל, החברה לקידום אבחון ט ומניעה שפמ. חוברת מענים לנפגעות/י טראומה מינית - ריכוז שירותים במערכות הבריאות והרווחה (Internet). 2021 (cited 2021 Dec 23). Available from: https://www.pulseem.com/Pulseem/ClientDocs/2518///%D7%97%D7%95%D7%91%D7%A8%D 7%AA%20%D7%9E%D7%A2%D7%A0%D7%99%D7%9D%20%D7%9C%D7%A0%D7%A4%D7%92% D7%A2%D7%95%D7%AAz%D7%99%20%D7%98%D7%A8%D7%90%D7%95%D7%9E%D7%94%20 %D7%9E%D7%99%D7%A0%D7%99%D7%AA%20-%20%D7%90%D7%95%D7%92%D7%95%D7%A1 %D7%98%202021.pdf
  1239. חובת ההודעה על נפגעי אלימות במשפחה, ניצול מיני והזנחה של קטינים וחסרי ישע - חוזר משרד הבריאות
  1240. איתור זיהוי וטיפול בקטינים נפגעי התעללות והזנחה - חוזר משרד הבריאות
  1241. הנחיות איגוד רופאי המשפחה לעבודה בתקופת מגיפת ה-The Israeli association of family physicians COVID-19 guidelines - COVID-19
  1242. משרד הבריאות. נוהל טיפול בנפגעי/ות תקיפה מינית (Internet). 24/03 2003. Available from: https://www.health.gov.il/hozer/mk24 2003.pdf
  1243. בדיקות בבתי החולים, במקרים בהם עלה חשד לשימוש בחומרים (סם האונס או חומרים פסיכואקטיביים אחרים) בהקשר של תקיפה מינית - חוזר משרד הבריאות
  1244. The Royal Australian College of General Practitioners. Abuse and violence: Working with our patients in general practice. 4th ed. Melbourne: The Royal Australian College of General Practitioners; 2014.
  1245. משרד הבריאות. כלי לאיתור זקנים נפגעי התעללות (Internet). 12223301111. 2011 (cited 2021 Dec 23). Available from: https://www.health.gov.il/UnitsOffice/HD/MHealth/CRD/Documents/Screeningtooltodiagnoseelderlyvictimsofabuse.pdf
  1246. נחמני-רוט ד, וייגלר ר, אלון ש, יוז פ. מיהו חסר ישע? המלצות ועדת ההיגוי הבין-משרדית לעניין הגדרת האדם הזקן כ"חסר ישע" (Internet). 2011 ;ירושלים: משרד הבריאות (cited 2021 Dec 23). Available from: https://www.dmag.co.il/pub/jdc/Abuse1/4/#zoom=z
  1247. משרד הבריאות. מינוי ועדות קבועות לנושא אלימות במשפחה, ניצול מיני (Internet). 26/03 2003. Available from: https://www.gov.il/he/departments/policies/mk26-2003
  1248. Wang B, Zhan S, Gong T, Lee L. Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Vol. 2013, Cochrane Database of Systematic Reviews. 2013.
  1249. Siu AL. Screening for iron deficiency anemia in young children: USPSTF recommendation statement. Pediatrics. 2015;136(4).
  1250. Dunn J, Henrikson NB, Morrison CC, Blasi PR, Nguyen M, Lin JS. Screening for adolescent idiopathic scoliosis evidence report and systematic review for the US preventive services task force. Vol. 319, JAMA - Journal of the American Medical Association. 2018.
  1251. Negrini S, Minozzi S, Bettany-Saltikov J, Chockalingam N, Grivas TB, Kotwicki T, et al. Braces for idiopathic scoliosis in adolescents. Vol. 2015, Cochrane Database of Systematic Reviews. 2015.
  1252. לוריא א, פורת נ, אמסטר ר. בריאות האישה: מהן הבדיקות שכל אישה חייבת לעבור כדי לשמור על בריאותה? הרפואה 2011;150(11).
  1253. Choosing Wisely. American Academy of Family Physicians (Internet). 2018 (cited 2021 Dec 22). Available from: https://www.choosingwisely.org/clinician-lists/aafp-pelvic-exams-on-asymptomatic-nonpregnant- women-to-screen-for-cervicah-cancerZ
  1254. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Ebell M, Epling JW, et al. Screening for skin cancer US preventive services task force recommendation statement. JAMA - Journal of the American Medical Association. 2016;316(4).
  1255. Johansson M, Brodersen J, G0tzsche PC, J0rgensen KJ. Screening for reducing morbidity and mortality in malignant melanoma. Vol. 2019, Cochrane Database of Systematic Reviews. 2019.
  1256. Coosing Wisely. Five Things Physicians and Patients Should Question (Internet). 2019 (cited 2021 Dec 22). Available from: https://www.choosingwisely.org/societies/american-college-of-cardiology/
  1257. LeFevre ML, Siu AL, Bibbins-Domingo K, Baumann LC, Karina WD, Ebell M, et al. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Vol. 162, Annals of Internal Medicine. 2015.
  1258. Lin JS, Aiello Bowles EJ, Williams SB, Morrison CC. Screening for thyroid cancer: Updated evidence report and systematic review for the US preventive services task force. Vol. 317, JAMA - Journal of the American Medical Association. 2017.
  1259. Moran PS, Teljeur C, Ryan M, Smith SM. Systematic screening for the detection of atrial fibrillation. Vol. 2016, Cochrane Database of Systematic Reviews. 2016.
  1260. Jin J. Screening for atrial fibrillation with electrocardiography. JAMA - Journal of the American Medical Association. 2018;320(5).
  1261. Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 2021 Jan;99)1(:34-47.